Last Close
Feb 20  •  04:00PM ET
504.05
Dollar change
+4.52
Percentage change
0.90
%
IndexNDX, S&P 500 P/E64.00 EPS (ttm)7.88 Insider Own0.63% Shs Outstand355.10M Perf Week5.32%
Market Cap179.00B Forward P/E43.93 EPS next Y11.47 Insider Trans-7.18% Shs Float352.88M Perf Month-3.75%
Enterprise Value173.36B PEG3.13 EPS next Q2.13 Inst Own85.71% Short Float2.03% Perf Quarter-7.81%
Income2.86B P/S17.79 EPS this Y12.44% Inst Trans-0.63% Short Ratio3.81 Perf Half Y4.91%
Sales10.06B P/B10.04 EPS next Y14.26% ROA14.47% Short Interest7.17M Perf YTD-11.00%
Book/sh50.19 P/C30.16 EPS next 5Y14.04% ROE16.67% 52W High608.16 -17.12% Perf Year-16.90%
Cash/sh16.71 P/FCF71.87 EPS past 3/5Y29.18% 21.79% ROIC15.91% 52W Low425.00 18.60% Perf 3Y110.98%
Dividend Est.- EV/EBITDA48.51 Sales past 3/5Y17.39% 18.22% Gross Margin65.98% Volatility2.47% 2.64% Perf 5Y101.58%
Dividend TTM- EV/Sales17.22 EPS Y/Y TTM22.44% Oper. Margin29.27% ATR (14)13.07 Perf 10Y730.34%
Dividend Ex-Date- Quick Ratio3.96 Sales Y/Y TTM20.51% Profit Margin28.38% RSI (14)46.49 Recom1.89
Dividend Gr. 3/5Y- - Current Ratio4.87 EPS Q/Q17.04% SMA201.05% Beta1.66 Target Price618.90
Payout0.00% Debt/Eq0.01 Sales Q/Q18.76% SMA50-6.07% Rel Volume0.82 Prev Close499.53
Employees17021 LT Debt/Eq0.01 EarningsJan 22 AMC SMA200-2.22% Avg Volume1.88M Price504.05
IPOJun 13, 2000 Option/ShortYes / Yes EPS/Sales Surpr.11.58% 3.75% Trades Volume1,553,265 Change0.90%
Date Action Analyst Rating Change Price Target Change
Jan-27-26Initiated TD Cowen Buy $660
Dec-11-25Downgrade Citigroup Buy → Neutral $635
Jul-23-25Downgrade Erste Group Buy → Hold
Jun-09-25Downgrade Deutsche Bank Hold → Sell $440
Jun-05-25Upgrade Erste Group Hold → Buy
Dec-02-24Upgrade Morgan Stanley Equal-Weight → Overweight $522 → $650
Aug-02-24Upgrade Redburn Atlantic Neutral → Buy $380 → $510
Jul-10-24Reiterated Citigroup Buy $462 → $512
May-30-24Initiated Goldman Buy $500
Nov-17-23Initiated HSBC Securities Buy $318
Feb-20-26 12:22PM
11:48AM
11:44AM
09:11AM
Feb-19-26 12:08PM
11:01AM Loading…
11:01AM
09:30AM
08:33AM
08:16AM
08:09AM
07:56AM
Feb-18-26 01:09PM
10:53AM
09:51AM
09:48AM
08:55AM Loading…
08:55AM
Feb-17-26 01:11PM
11:20AM
11:12AM
10:07AM
09:42AM
09:00AM
03:33AM
Feb-16-26 11:32AM
10:52AM
10:05AM
Feb-13-26 12:35PM
09:38AM
Feb-12-26 01:07PM
12:57PM
11:03AM Loading…
11:03AM
10:54AM
09:23AM
09:18AM
08:24AM
Feb-11-26 09:37PM
11:14AM
08:17AM
Feb-10-26 01:00PM
12:20PM
10:43AM
Feb-09-26 12:58PM
10:06AM
Feb-06-26 01:22PM
09:00AM
08:07AM
08:03AM
Feb-05-26 10:42AM
08:09AM
Feb-04-26 12:51PM
Feb-03-26 10:27PM
01:17PM
09:30AM
Feb-02-26 09:42AM
Jan-31-26 05:24PM
11:37AM
11:23AM
08:05AM
Jan-30-26 05:10PM
08:40AM
08:28AM
06:12AM
Jan-29-26 08:29AM
12:35AM
Jan-28-26 03:14AM
Jan-27-26 12:07PM
09:50AM
08:00AM
Jan-26-26 09:50AM
09:15AM
09:00AM
05:06AM
Jan-25-26 11:44AM
Jan-24-26 08:55AM
04:05AM
Jan-23-26 06:50PM
04:02PM
12:10PM
11:43AM
11:07AM
10:07AM
10:00AM
09:57AM
09:26AM
09:15AM
07:59AM
06:31AM
06:06AM
04:30AM
12:02AM
Jan-22-26 08:36PM
08:27PM
08:00PM
06:42PM
05:20PM
04:45PM
04:45PM
04:34PM
04:19PM
04:05PM
Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRIAN MILLEROfficerFeb 18 '26Proposed Sale493.35647319,197Feb 18 04:37 PM
Curet MyriamEVP & Chief Medical OfficerFeb 10 '26Option Exercise25.5494324,0861,247Feb 11 05:37 PM
Curet MyriamEVP & Chief Medical OfficerFeb 11 '26Sale494.96421208,378409Feb 11 05:37 PM
Curet MyriamEVP & Chief Medical OfficerFeb 10 '26Sale494.6510551,938830Feb 11 05:37 PM
Widman FredrikVP Corporate ControllerFeb 10 '26Option Exercise0.0056701,095Feb 11 05:17 PM
Widman FredrikVP Corporate ControllerFeb 11 '26Sale494.9613365,830660Feb 11 05:17 PM
FREDRIK WIDMANOfficerFeb 11 '26Proposed Sale494.9613365,830Feb 11 04:05 PM
MYRIAM CURET MCADAMSOfficerFeb 11 '26Proposed Sale494.96421208,378Feb 11 04:02 PM
Rosa David J.Chief Executive Officer (CEO)Feb 10 '26Option Exercise0.001,4360230,294Feb 10 04:28 PM
GUTHART GARY SDirectorFeb 10 '26Option Exercise0.002,63306,327Feb 10 04:18 PM
MYRIAM CURET MCADAMSOfficerFeb 10 '26Proposed Sale494.6510551,938Feb 10 04:04 PM
LOEB GARYEVP & Chief Legal and ComplianFeb 10 '26Option Exercise0.0031503,876Feb 10 03:51 PM
Jeddi ImanSVP & GM da Vinci Platforms &Feb 10 '26Option Exercise0.008380894Feb 10 03:26 PM
Samath JamieEVP & CFO & Enterprise TechnolFeb 10 '26Option Exercise0.001,07708,295Feb 10 03:16 PM
Charlton Henry LEVP & Chief Commercial and MktFeb 10 '26Option Exercise0.001,07704,189Feb 10 02:16 PM
Brosius MarkSVP & Chief Mfg and Supply ChaFeb 10 '26Option Exercise0.0083801,025Feb 10 01:54 PM
Curet MyriamEVP & Chief Medical OfficerJan 29 '26Option Exercise208.9012626,321126Jan 30 09:16 PM
Curet MyriamEVP & Chief Medical OfficerJan 29 '26Sale520.0212665,5230Jan 30 09:16 PM
MYRIAM CURET MCADAMSOfficerJan 29 '26Proposed Sale520.0212665,523Jan 29 04:01 PM
Curet MyriamEVP & Chief Medical OfficerJan 27 '26Option Exercise218.2523050,198125Jan 28 04:34 PM
Curet MyriamEVP & Chief Medical OfficerJan 27 '26Sale532.61230122,5000Jan 28 04:34 PM
GUTHART GARY SDirectorJan 27 '26Option Exercise174.2625,5004,443,54628,194Jan 28 04:20 PM
GUTHART GARY SDirectorJan 27 '26Sale530.1024,50012,987,4033,694Jan 28 04:20 PM
GUTHART GARY SDirectorJan 27 '26Sale531.522,8001,488,26915,720Jan 28 04:20 PM
GARY S GUTHARTOfficerJan 27 '26Proposed Sale530.1024,50012,987,403Jan 27 05:18 PM
MYRIAM CURET MCADAMSOfficerJan 27 '26Proposed Sale532.61230122,500Jan 27 04:01 PM
GUTHART GARY SOfficerJan 27 '26Proposed Sale531.522,8001,488,269Jan 27 11:11 AM
Brosius MarkSee RemarksDec 15 '25Sale548.49464254,499131Dec 17 06:59 PM
Brosius MarkSVP & Chief Mfg and Supply ChaDec 12 '25Option Exercise79.644,500358,3705,407Dec 15 06:52 PM
Brosius MarkSVP & Chief Mfg and Supply ChaDec 12 '25Sale547.364,5002,463,120907Dec 15 06:52 PM
Brosius MarkSVP & Chief Mfg and Supply ChaDec 15 '25Sale548.49464254,499443Dec 15 06:52 PM
MARK BROSIUSOfficerDec 12 '25Proposed Sale547.365,2762,887,871Dec 12 04:19 PM
Curet MyriamEVP & Chief Medical OfficerDec 10 '25Option Exercise229.3910423,857104Dec 10 06:23 PM
Curet MyriamEVP & Chief Medical OfficerDec 10 '25Sale559.9010458,2300Dec 10 06:23 PM
MYRIAM CURET MCADAMSOfficerDec 10 '25Proposed Sale559.9010458,230Dec 10 04:01 PM
Curet MyriamEVP & Chief Medical OfficerDec 01 '25Option Exercise208.9012526,112125Dec 02 04:16 PM
Curet MyriamEVP & Chief Medical OfficerDec 01 '25Sale568.9912571,1240Dec 02 04:16 PM
GUTHART GARY SExecutive Chair of the Board oDec 01 '25Option Exercise139.5225,5003,557,76025,500Dec 02 12:50 PM
GUTHART GARY SExecutive Chair of the Board oDec 01 '25Sale570.8922,80613,019,7222,694Dec 02 12:50 PM
GARY S GUTHARTOfficerDec 01 '25Proposed Sale570.8922,80613,019,722Dec 01 04:48 PM
MYRIAM CURET MCADAMSOfficerDec 01 '25Proposed Sale568.9912571,124Dec 01 04:05 PM
Charlton Henry LEVP & Chief Commercial and MktNov 12 '25Option Exercise229.959,0002,069,55210,688Nov 13 01:55 PM
Charlton Henry LEVP & Chief Commercial and MktNov 12 '25Sale580.0013,7317,963,9803,056Nov 13 01:55 PM
BARRATT CRAIG HDirectorNov 12 '25Option Exercise71.3275053,492750Nov 13 01:46 PM
BARRATT CRAIG HDirectorNov 12 '25Sale580.00750435,0000Nov 13 01:46 PM
HENRY CHARLTONOfficerNov 12 '25Proposed Sale580.0013,7317,963,980Nov 12 04:04 PM
CRAIG H BARRATTDirectorNov 12 '25Proposed Sale580.00750435,000Nov 12 04:01 PM
Curet MyriamEVP & Chief Medical OfficerNov 10 '25Option Exercise229.3910524,086105Nov 12 02:12 PM
Curet MyriamEVP & Chief Medical OfficerNov 10 '25Sale560.0010558,8000Nov 12 02:12 PM
Miller Brian EdwardEVP & Chief Digital OfficerNov 10 '25Option Exercise216.503,500757,7467,960Nov 12 02:03 PM
Miller Brian EdwardEVP & Chief Digital OfficerNov 10 '25Sale575.003,5002,012,5005,758Nov 12 02:03 PM
BRIAN MILLEROfficerNov 10 '25Proposed Sale575.003,5002,012,500Nov 10 06:18 PM
MYRIAM CURET MCADAMSOfficerNov 10 '25Proposed Sale560.0010558,800Nov 10 04:01 PM
Widman FredrikVP Corporate ControllerNov 05 '25Option Exercise75.652,067156,3682,381Nov 06 02:17 PM
Widman FredrikVP Corporate ControllerNov 05 '25Sale550.002,0671,136,850473Nov 06 02:17 PM
FREDRIK WIDMANOfficerNov 05 '25Proposed Sale550.002,0671,136,850Nov 05 04:36 PM
Curet MyriamEVP & Chief Medical OfficerOct 28 '25Option Exercise234.277,5621,771,5135,383Oct 29 07:48 PM
Curet MyriamEVP & Chief Medical OfficerOct 29 '25Option Exercise208.9012526,112125Oct 29 07:48 PM
Curet MyriamEVP & Chief Medical OfficerOct 28 '25Sale548.437,5624,147,193353Oct 29 07:48 PM
Curet MyriamEVP & Chief Medical OfficerOct 29 '25Sale543.0012567,8750Oct 29 07:48 PM
MYRIAM CURET MCADAMSOfficerOct 29 '25Proposed Sale543.0012567,875Oct 29 04:06 PM
MYRIAM CURET MCADAMSOfficerOct 28 '25Proposed Sale548.437,5624,147,192Oct 28 04:09 PM
GUTHART GARY SExecutive Chair of the Board oOct 24 '25Option Exercise109.4936,0003,941,48255,827Oct 27 04:11 PM
GUTHART GARY SExecutive Chair of the Board oOct 24 '25Sale547.5628,80015,769,64427,027Oct 27 04:11 PM
GUTHART GARY SExecutive Chair of the Board oOct 24 '25Sale546.272,8001,529,54717,120Oct 27 04:11 PM
BARRATT CRAIG HDirectorOct 24 '25Option Exercise71.322,193156,4122,193Oct 27 03:56 PM
BARRATT CRAIG HDirectorOct 24 '25Sale548.012,1931,201,7860Oct 27 03:56 PM
Rosa David J.Chief Executive Officer (CEO)Oct 24 '25Option Exercise79.6427,0002,150,221258,756Oct 27 03:36 PM
Rosa David J.Chief Executive Officer (CEO)Oct 24 '25Sale547.5524,50013,414,980234,256Oct 27 03:36 PM
GARY S GUTHARTOfficerOct 24 '25Proposed Sale547.5628,80015,769,644Oct 24 04:34 PM
DAVID ROSAOfficerOct 24 '25Proposed Sale547.5524,50013,414,977Oct 24 04:29 PM
CRAIG H BARRATTDirectorOct 24 '25Proposed Sale548.012,1931,201,786Oct 24 04:05 PM
LOEB GARYEVP & Chief Legal and ComplianOct 10 '25Option Exercise0.002,61204,857Oct 10 02:25 PM
Ladd Amy LDirectorSep 03 '25Sale470.11336157,9571,074Sep 04 06:55 PM
Ladd Amy LDirectorSep 04 '25Sale440.69335147,631739Sep 04 06:55 PM
AMY L LADDDirectorSep 04 '25Proposed Sale440.69335147,631Sep 04 04:05 PM
AMY L LADDDirectorSep 03 '25Proposed Sale470.11336157,957Sep 03 04:01 PM
GUTHART GARY SExecutive Chair of the Board oAug 29 '25Option Exercise79.6436,0002,866,96149,187Sep 02 04:16 PM
GUTHART GARY SExecutive Chair of the Board oAug 29 '25Sale472.4929,36013,872,22719,827Sep 02 04:16 PM
GARY S GUTHARTOfficerAug 29 '25Proposed Sale472.4929,36013,872,227Aug 29 04:35 PM
GUTHART GARY SExecutive Chair of the Board oJul 28 '25Option Exercise59.467,893469,33521,080Jul 29 01:02 PM
GUTHART GARY SExecutive Chair of the Board oJul 28 '25Sale498.647,8933,935,75613,187Jul 29 01:02 PM
GUTHART GARY SExecutive Chair of the Board oJul 28 '25Sale495.242,8001,386,66318,520Jul 29 01:02 PM
GARY S GUTHARTOfficerJul 28 '25Proposed Sale498.647,8933,935,755Jul 28 04:25 PM
GUTHART GARY SOfficerJul 28 '25Proposed Sale495.245,6002,773,344Jul 28 10:17 AM
Curet MyriamEVP & Chief Medical OfficerJul 25 '25Option Exercise242.344,5001,090,5154,853Jul 25 06:50 PM
Curet MyriamEVP & Chief Medical OfficerJul 25 '25Sale492.484,5002,216,160353Jul 25 06:50 PM
MYRIAM CURET MCADAMSOfficerJul 25 '25Proposed Sale492.484,5002,216,160Jul 25 04:10 PM
ROBERT DESANTISOfficerJun 10 '25Proposed Sale525.81240126,194Jun 10 04:01 PM
Rosa David J.PresidentJun 10 '25Option Exercise0.001,3580232,430Jun 10 12:36 PM
Brosius MarkSVP & Chief Mfg and Supply ChaJun 06 '25Sale563.11216121,632907Jun 06 04:20 PM
Brosius MarkSVP & Chief Mfg and Supply ChaJun 05 '25Sale560.70215120,5511,123Jun 06 04:20 PM
MARK BROSIUSOfficerJun 06 '25Proposed Sale563.11216121,632Jun 06 04:05 PM
MARK BROSIUSOfficerJun 05 '25Proposed Sale560.70215120,550Jun 05 04:48 PM
Brosius MarkSVP & Chief Mfg and Supply ChaJun 04 '25Sale552.07215118,6951,338Jun 04 06:44 PM
Brosius MarkSVP & Chief Mfg and Supply ChaJun 03 '25Sale550.68215118,3961,553Jun 04 06:44 PM
Brosius MarkSVP & Chief Mfg and Supply ChaJun 02 '25Sale549.06215118,0481,768Jun 04 06:44 PM
MARK BROSIUSOfficerJun 04 '25Proposed Sale552.07215118,695Jun 04 04:01 PM
MARK BROSIUSOfficerJun 03 '25Proposed Sale550.68215118,396Jun 03 04:36 PM
MARK BROSIUSOfficerJun 02 '25Proposed Sale549.06215118,048Jun 02 04:04 PM
Last Close
Feb 20  •  04:00PM ET
2.26
Dollar change
+0.42
Percentage change
22.83
%
RBOT Vicarious Surgical Inc daily Stock Chart
Index- P/E- EPS (ttm)-9.04 Insider Own41.35% Shs Outstand5.31M Perf Week27.68%
Market Cap16.08M Forward P/E- EPS next Y-4.07 Insider Trans-0.19% Shs Float4.17M Perf Month-6.22%
Enterprise Value15.56M PEG- EPS next Q-1.37 Inst Own15.59% Short Float7.47% Perf Quarter-23.91%
Income-53.59M P/S- EPS this Y24.74% Inst Trans-3.64% Short Ratio2.24 Perf Half Y-61.69%
Sales0.00M P/B0.96 EPS next Y49.69% ROA-97.47% Short Interest0.31M Perf YTD4.15%
Book/sh2.36 P/C1.20 EPS next 5Y41.34% ROE-148.93% 52W High15.86 -85.75% Perf Year-84.54%
Cash/sh1.88 P/FCF- EPS past 3/5Y0.56% -634.04% ROIC-209.20% 52W Low1.71 32.16% Perf 3Y-97.55%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility12.75% 10.29% Perf 5Y-99.28%
Dividend TTM- EV/Sales- EPS Y/Y TTM15.03% Oper. Margin- ATR (14)0.24 Perf 10Y-
Dividend Ex-Date- Quick Ratio4.75 Sales Y/Y TTM- Profit Margin- RSI (14)54.20 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio4.75 EPS Q/Q35.90% SMA2011.00% Beta1.56 Target Price5.00
Payout- Debt/Eq0.91 Sales Q/Q- SMA50-0.99% Rel Volume1.79 Prev Close1.84
Employees123 LT Debt/Eq0.82 EarningsNov 12 AMC SMA200-59.75% Avg Volume139.32K Price2.26
IPOSep 04, 2020 Option/ShortNo / Yes EPS/Sales Surpr.17.91% - Trades Volume248,978 Change22.83%
Date Action Analyst Rating Change Price Target Change
Mar-04-22Downgrade Piper Sandler Overweight → Neutral $16 → $7
Jan-07-22Initiated Credit Suisse Outperform $16
Dec-07-21Initiated Cowen Outperform $15
Nov-05-21Initiated Canaccord Genuity Buy $15
Oct-18-21Initiated BTIG Research Buy $15
Oct-07-21Initiated Piper Sandler Overweight $16
Jan-12-26 08:30AM
Jan-06-26 05:07AM
Dec-30-25 10:42AM
Dec-29-25 04:10PM
Dec-15-25 08:30AM
07:00AM Loading…
Dec-03-25 07:00AM
Nov-19-25 04:15PM
Nov-14-25 06:09AM
Nov-13-25 12:02AM
Nov-12-25 04:15PM
Nov-06-25 06:13PM
Oct-30-25 04:05PM
Oct-08-25 07:00AM
Sep-25-25 04:15PM
Aug-27-25 04:15PM
07:42AM Loading…
Aug-14-25 07:42AM
Aug-13-25 12:33PM
03:13AM
Aug-12-25 04:15PM
Aug-01-25 11:51AM
Jul-31-25 04:30PM
Jul-29-25 04:05PM
Jun-30-25 06:45AM
May-28-25 08:30AM
May-13-25 03:09AM
May-12-25 04:05PM
04:05PM
Apr-28-25 04:05PM
Apr-11-25 04:30PM
Mar-24-25 04:05PM
12:00PM Loading…
Mar-20-25 12:00PM
Mar-17-25 04:05PM
Mar-13-25 08:30AM
Mar-03-25 04:05PM
Feb-18-25 04:05PM
Dec-06-24 04:05PM
Nov-12-24 04:05PM
Oct-29-24 08:30AM
Aug-21-24 08:30AM
Aug-12-24 04:05PM
Aug-07-24 08:30AM
Jul-29-24 04:10PM
Jun-10-24 04:15PM
May-22-24 07:23AM
May-01-24 09:36AM
Apr-30-24 03:05AM
Apr-29-24 08:54PM
04:05PM
Apr-08-24 04:30PM
Mar-04-24 04:10PM
Feb-20-24 08:30AM
Feb-12-24 04:30PM
Jan-29-24 08:30AM
Nov-15-23 08:30AM
Nov-14-23 08:45AM
Nov-13-23 04:05PM
Oct-26-23 09:00AM
Sep-22-23 05:00PM
Sep-12-23 08:00AM
Sep-07-23 04:30PM
Aug-03-23 04:30PM
Aug-02-23 10:25PM
04:45PM
Jul-27-23 04:05PM
Jul-13-23 04:15PM
May-18-23 04:05PM
May-08-23 04:05PM
May-04-23 09:00AM
Apr-24-23 04:30PM
Feb-22-23 09:00AM
Feb-13-23 04:05PM
Jan-30-23 09:00AM
Jan-23-23 04:10PM
Dec-22-22 06:46PM
Nov-17-22 09:00AM
Nov-14-22 08:30AM
Nov-10-22 09:25AM
Nov-07-22 04:05PM
08:00AM
Oct-24-22 08:00AM
Oct-20-22 04:15PM
Oct-13-22 08:00AM
Aug-17-22 04:15PM
Aug-08-22 04:05PM
Jul-27-22 04:15PM
Jul-25-22 04:15PM
Jul-07-22 04:05PM
Jun-21-22 09:00AM
Jun-08-22 04:30PM
May-09-22 04:05PM
May-08-22 09:06AM
Apr-18-22 04:15PM
Mar-29-22 04:34PM
Mar-24-22 05:30PM
Mar-03-22 04:05PM
Mar-01-22 08:00AM
Feb-23-22 04:10PM
Feb-02-22 04:10PM
Jan-24-22 01:38PM
Jan-05-22 09:35AM
Vicarious Surgical, Inc. a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It also designs surgical robotics. The company was founded by Adam Sachs, Sammy Khalifa, and Barry Greene on May 1, 2014 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Adam SachsOfficerFeb 20 '26Proposed Sale1.849421,733Feb 20 10:38 AM
Sammy KhalifaOfficerFeb 20 '26Proposed Sale1.847541,387Feb 20 10:38 AM
Sachs Adam DavidPresidentDec 03 '25Sale2.954631,36747,885Dec 04 07:14 PM
Khalifa SammyChief Technology OfficerDec 03 '25Sale2.9723971033,623Dec 04 07:13 PM
Adam SachsOfficerDec 03 '25Proposed Sale2.594631,199Dec 03 10:48 AM
Sammy KhalifaOfficerDec 03 '25Proposed Sale2.59239619Dec 03 10:48 AM
Khalifa SammyChief Technology OfficerNov 20 '25Sale2.746531,79233,862Nov 21 07:28 PM
Sachs Adam DavidPresidentNov 20 '25Sale2.718162,21548,348Nov 21 07:27 PM
Adam SachsOfficerNov 20 '25Proposed Sale2.818162,293Nov 20 06:28 PM
Sammy KhalifaOfficerNov 20 '25Proposed Sale2.816531,835Nov 20 06:28 PM
Tang Donald FFormer DirectorSep 22 '25Proposed Sale5.8532,469189,944Sep 22 01:13 PM
Sachs Adam DavidPresidentSep 03 '25Sale5.764632,66549,164Sep 04 04:47 PM
Khalifa SammyChief Technology OfficerSep 03 '25Sale5.722391,36734,515Sep 04 04:46 PM
Adam SachsOfficerSep 03 '25Proposed Sale5.804632,685Sep 03 10:25 AM
Sammy KhalifaOfficerSep 03 '25Proposed Sale5.802391,386Sep 03 10:25 AM
Tang Donald FDirectorAug 26 '25Sale6.702,75318,43540,425Aug 27 04:57 PM
Khalifa SammyChief Technology OfficerAug 20 '25Sale6.046533,94634,754Aug 21 07:53 PM
Sachs Adam DavidPresidentAug 20 '25Sale6.038174,92749,627Aug 21 07:53 PM
Tang Donald FDirectorAug 20 '25Sale6.042,05912,43643,178Aug 21 07:53 PM
Tang Donald FDirectorAug 19 '25Sale6.6810066845,237Aug 21 07:53 PM
Adam SachsOfficerAug 20 '25Proposed Sale6.388175,212Aug 20 10:40 AM
Sammy KhalifaOfficerAug 20 '25Proposed Sale6.386534,166Aug 20 10:40 AM
Sachs Adam DavidCEOJun 23 '25Sale7.802792,17650,444Jun 24 06:49 PM
Khalifa SammyChief Technology OfficerJun 23 '25Sale7.812231,74335,407Jun 24 06:48 PM
Adam SachsOfficerJun 23 '25Proposed Sale7.982792,226Jun 23 12:37 PM
Sammy KhalifaOfficerJun 23 '25Proposed Sale7.982231,780Jun 23 12:37 PM
John MazzolaOfficerJun 13 '25Proposed Sale8.191,1359,296Jun 13 01:44 PM
Khalifa SammyChief Technology OfficerJun 03 '25Sale7.252391,73335,630Jun 04 02:16 PM
Sachs Adam DavidCEOJun 03 '25Sale7.224633,34350,723Jun 04 02:16 PM
Adam SachsOfficerJun 03 '25Proposed Sale7.534633,486Jun 03 11:31 AM
Sammy KhalifaOfficerJun 03 '25Proposed Sale7.532391,800Jun 03 11:31 AM
Khalifa SammyChief Technology OfficerMay 20 '25Sale7.526534,91235,869May 21 01:19 PM
Sachs Adam DavidCEOMay 20 '25Sale7.538176,15051,186May 21 01:19 PM
Sammy KhalifaOfficerMay 20 '25Proposed Sale7.626534,976May 20 11:55 AM
Adam SachsOfficerMay 20 '25Proposed Sale7.628176,226May 20 11:30 AM
John MazzolaOfficerApr 28 '25Proposed Sale9.203,57632,916May 01 04:48 PM
Sachs Adam DavidCEOMar 21 '25Sale7.921611,27552,003Mar 24 04:51 PM
Khalifa SammyChief Technology OfficerMar 21 '25Sale7.971291,02836,522Mar 24 04:50 PM
Adam SachsOfficerMar 21 '25Proposed Sale8.001611,288Mar 21 12:26 PM
Sammy KhalifaOfficerMar 21 '25Proposed Sale8.001291,032Mar 21 12:23 PM
William KellyOfficerMar 21 '25Proposed Sale8.0021168Mar 21 12:21 PM
Khalifa SammyChief Technology OfficerMar 03 '25Sale10.252762,83036,651Mar 04 04:57 PM
Mazzola JohnChief Operating OfficerMar 03 '25Sale10.282642,7139,498Mar 04 04:56 PM
Sachs Adam DavidCEOMar 03 '25Sale10.285355,49952,164Mar 04 04:55 PM
Adam SachsOfficerMar 03 '25Proposed Sale11.005355,885Mar 03 11:04 AM
Sammy KhalifaOfficerMar 03 '25Proposed Sale11.002763,036Mar 03 11:04 AM
John MazzolaOfficerMar 03 '25Proposed Sale11.002642,904Mar 03 11:04 AM
William KellyOfficerMar 03 '25Proposed Sale11.002512,761Mar 03 11:04 AM
Last Close
Feb 20  •  04:00PM ET
79.78
Dollar change
+0.86
Percentage change
1.09
%
EW Edwards Lifesciences Corp daily Stock Chart
IndexS&P 500 P/E43.06 EPS (ttm)1.85 Insider Own1.40% Shs Outstand580.30M Perf Week4.37%
Market Cap46.30B Forward P/E24.05 EPS next Y3.32 Insider Trans-1.38% Shs Float572.16M Perf Month-6.30%
Enterprise Value43.90B PEG1.80 EPS next Q0.73 Inst Own88.38% Short Float1.41% Perf Quarter-5.07%
Income1.09B P/S7.63 EPS this Y15.90% Inst Trans0.10% Short Ratio2.10 Perf Half Y-1.98%
Sales6.07B P/B4.54 EPS next Y11.79% ROA10.23% Short Interest8.09M Perf YTD-6.42%
Book/sh17.57 P/C15.43 EPS next 5Y13.39% ROE13.59% 52W High87.89 -9.23% Perf Year6.79%
Cash/sh5.17 P/FCF57.57 EPS past 3/5Y-9.12% 7.03% ROIC9.99% 52W Low65.94 20.99% Perf 3Y1.62%
Dividend Est.- EV/EBITDA24.96 Sales past 3/5Y4.08% 6.70% Gross Margin79.71% Volatility2.84% 2.82% Perf 5Y-5.37%
Dividend TTM- EV/Sales7.23 EPS Y/Y TTM26.82% Oper. Margin26.75% ATR (14)2.26 Perf 10Y177.62%
Dividend Ex-Date- Quick Ratio3.29 Sales Y/Y TTM6.00% Profit Margin17.92% RSI (14)47.59 Recom1.77
Dividend Gr. 3/5Y- - Current Ratio4.00 EPS Q/Q-75.99% SMA20-0.22% Beta0.94 Target Price96.93
Payout0.00% Debt/Eq0.06 Sales Q/Q13.26% SMA50-3.73% Rel Volume1.23 Prev Close78.92
Employees15800 LT Debt/Eq0.06 EarningsFeb 10 AMC SMA2000.17% Avg Volume3.85M Price79.78
IPOMar 27, 2000 Option/ShortYes / Yes EPS/Sales Surpr.-6.13% 1.47% Trades Volume4,730,313 Change1.09%
Date Action Analyst Rating Change Price Target Change
Jan-09-26Upgrade TD Cowen Hold → Buy $97
Dec-18-25Upgrade JP Morgan Neutral → Overweight $100
Nov-03-25Upgrade Raymond James Mkt Perform → Outperform $96
Oct-29-25Upgrade Wolfe Research Underperform → Peer Perform
Oct-29-25Upgrade Jefferies Hold → Buy $98
Oct-08-25Downgrade Oppenheimer Outperform → Perform
Oct-07-25Upgrade Evercore ISI In-line → Outperform $88
Jul-29-25Upgrade BTIG Research Neutral → Buy $100
Apr-24-25Upgrade Piper Sandler Neutral → Overweight $80
Jan-30-25Upgrade Stifel Hold → Buy $75 → $90
Feb-19-26 05:11PM
07:05AM
Feb-15-26 06:52AM
Feb-13-26 06:28PM
07:57AM
07:05AM Loading…
07:05AM
Feb-12-26 01:26PM
Feb-11-26 05:02PM
04:07PM
11:00AM
08:30AM
08:17AM
07:44AM
01:24AM
12:01AM
10:07PM Loading…
Feb-10-26 10:07PM
06:00PM
04:46PM
04:29PM
04:15PM
Feb-09-26 02:08PM
09:47AM
Feb-06-26 08:15AM
Feb-05-26 09:15AM
Feb-04-26 10:23AM
Feb-03-26 07:05AM
Feb-02-26 09:51PM
07:05AM
Jan-31-26 09:35AM
Jan-30-26 02:31PM
05:06AM Loading…
Jan-26-26 05:06AM
Jan-25-26 11:44AM
Jan-19-26 09:25AM
Jan-15-26 08:42AM
Jan-14-26 01:19PM
07:50AM
Jan-13-26 09:01AM
Jan-12-26 09:31AM
07:38AM
05:37AM
Jan-09-26 06:48PM
Dec-26-25 12:20PM
Dec-24-25 12:45PM
08:40AM
Dec-23-25 10:21AM
09:00AM
Dec-22-25 11:07AM
Dec-18-25 07:05AM
Dec-11-25 08:09AM
Dec-04-25 09:00AM
Dec-03-25 12:45PM
Dec-02-25 03:57AM
Nov-30-25 03:29PM
Nov-24-25 08:25AM
Nov-11-25 05:58AM
Nov-09-25 04:00PM
Nov-07-25 01:23PM
Nov-05-25 01:59PM
10:27AM
Oct-31-25 07:35PM
04:25PM
04:12PM
11:59AM
10:51AM
10:17AM
07:56AM
Oct-30-25 11:05PM
06:00PM
05:24PM
04:15PM
04:13PM
Oct-29-25 09:35AM
Oct-28-25 09:37AM
09:15AM
Oct-27-25 03:06PM
02:22PM
10:00AM
Oct-24-25 09:00AM
Oct-23-25 07:53AM
07:05AM
Oct-21-25 06:33AM
Oct-17-25 09:08AM
08:26AM
Oct-13-25 08:14AM
Oct-10-25 08:44AM
Oct-08-25 11:16AM
09:45AM
Oct-07-25 09:50AM
Oct-06-25 07:58AM
Oct-02-25 07:10AM
Sep-19-25 04:02PM
Sep-10-25 04:52AM
Sep-09-25 11:44AM
Sep-05-25 12:21PM
Sep-04-25 04:29PM
Sep-03-25 05:55AM
Sep-02-25 11:13AM
06:51AM
Sep-01-25 12:20PM
11:51AM
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zovighian Bernard JCEOFeb 12 '26Option Exercise59.2625,3501,502,157106,326Feb 13 05:37 PM
Zovighian Bernard JCEOFeb 12 '26Sale76.6722,4301,719,74183,896Feb 13 05:37 PM
Zovighian Bernard JOfficerFeb 12 '26Proposed Sale76.6722,4301,719,742Feb 12 04:54 PM
Lippis Daniel J.CVP, TAVRJan 09 '26Option Exercise59.261,01960,38323,021Jan 09 05:41 PM
Lippis Daniel J.CVP, TAVRJan 09 '26Sale85.701,01987,33222,002Jan 09 05:41 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJan 06 '26Option Exercise59.2611,340671,97143,210Jan 06 06:02 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJan 06 '26Sale85.6611,340971,42931,870Jan 06 06:02 PM
BOBO DONALD E JROfficerJan 06 '26Proposed Sale85.6645,3603,885,715Jan 06 04:04 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentDec 12 '25Sale83.7611,386953,74838,970Dec 12 05:57 PM
Lippis Daniel J.CVP, JAPACDec 12 '25Option Exercise59.261,01960,38323,021Dec 12 05:57 PM
Lippis Daniel J.CVP, JAPACDec 12 '25Sale84.031,01985,62522,002Dec 12 05:57 PM
STONE HEISZ LESLIEDirectorDec 12 '25Sale83.412,615218,12030,948Dec 12 05:57 PM
BOBO JR FAMILY TRUSTOfficerDec 12 '25Proposed Sale83.745,900494,066Dec 12 04:22 PM
STONE HEISZ LESLIEDirectorDec 12 '25Proposed Sale83.412,615218,119Dec 12 04:04 PM
BOBO DONALD E JROfficerDec 12 '25Proposed Sale83.785,487459,682Dec 12 04:03 PM
Chopra DaveenCVP, TMTT & SurgicalDec 11 '25Sale84.382,000168,75032,201Dec 11 05:58 PM
Chopra DaveenOfficerDec 11 '25Proposed Sale84.382,000168,750Dec 11 04:01 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentDec 10 '25Option Exercise59.2611,340671,97161,696Dec 10 06:58 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentDec 10 '25Sale83.8311,340950,58150,356Dec 10 06:58 PM
Zovighian Bernard JCEODec 08 '25Option Exercise59.2625,3501,502,157106,326Dec 10 06:58 PM
Zovighian Bernard JCEODec 08 '25Sale85.2121,4871,831,00684,839Dec 10 06:58 PM
Zovighian Bernard JCEODec 10 '25Sale83.453,863322,3678,597Dec 10 06:58 PM
BOBO DONALD E JROfficerDec 10 '25Proposed Sale83.8311,340950,582Dec 10 04:38 PM
Zovighian Bernard JOfficerDec 10 '25Proposed Sale83.453,863322,367Dec 10 04:37 PM
Ullem Scott B.CVP, Chief Financial OfficerDec 09 '25Option Exercise59.267,700456,27747,598Dec 09 05:01 PM
Ullem Scott B.CVP, Chief Financial OfficerDec 09 '25Sale84.477,700650,41239,898Dec 09 05:01 PM
Markowitz WayneCVP, JAPACDec 08 '25Sale86.0158350,14417,563Dec 08 05:50 PM
Markowitz WayneOfficerDec 08 '25Proposed Sale86.0158350,144Dec 08 04:13 PM
Zovighian Bernard JOfficerDec 08 '25Proposed Sale85.2121,4871,831,006Dec 08 04:12 PM
Wood Larry LFormer AffiliateNov 11 '25Proposed Sale85.1226,8502,285,355Nov 12 01:30 PM
Ullem Scott B.CVP, Chief Financial OfficerNov 10 '25Option Exercise59.2613,000770,33752,898Nov 10 06:07 PM
Ullem Scott B.CVP, Chief Financial OfficerNov 10 '25Sale83.0813,0001,080,09339,898Nov 10 06:07 PM
Lippis Daniel J.CVP, JAPACNov 10 '25Option Exercise59.261,02060,44223,022Nov 10 06:06 PM
Lippis Daniel J.CVP, JAPACNov 10 '25Sale82.551,02084,19622,002Nov 10 06:06 PM
Lippis Daniel J.OfficerNov 10 '25Proposed Sale82.553,058252,423Nov 10 04:08 PM
Ullem Scott B.OfficerNov 10 '25Proposed Sale83.0820,7001,719,841Nov 10 04:07 PM
Wood Larry LFormer AffiliateOct 16 '25Proposed Sale73.028,950653,522Oct 16 04:07 PM
Chopra DaveenCVP, TMTTAug 25 '25Sale81.952,500204,86530,996Aug 25 06:25 PM
Chopra DaveenOfficerAug 25 '25Proposed Sale81.952,500204,865Aug 25 04:15 PM
Wood Larry LGlobal President TAVR & SurgAug 18 '25Option Exercise59.268,950530,347215,850Aug 18 06:11 PM
Wood Larry LGlobal President TAVR & SurgAug 18 '25Sale78.068,950698,679206,900Aug 18 06:11 PM
Wood Larry LOfficerAug 18 '25Proposed Sale78.068,950698,679Aug 18 04:29 PM
Lippis Daniel J.CVP, JAPACJul 28 '25Sale79.464,114326,90022,002Jul 28 06:23 PM
Lippis Daniel J.OfficerJul 28 '25Proposed Sale79.464,114326,900Jul 28 04:04 PM
Wood Larry LGlobal President TAVR & SurgJun 16 '25Option Exercise59.268,950530,347215,850Jun 16 05:09 PM
Wood Larry LGlobal President TAVR & SurgJun 16 '25Sale75.238,950673,268206,900Jun 16 05:09 PM
Wood Larry LOfficerJun 16 '25Proposed Sale75.238,950673,268Jun 16 04:20 PM
Zovighian Bernard JCEOMay 30 '25Sale77.2116,0991,243,0659,564Jun 03 05:15 PM
Zovighian Bernard JCEOJun 03 '25Sale77.3296774,7728,597Jun 03 05:15 PM
Zovighian Bernard JOfficerJun 03 '25Proposed Sale77.3296774,772Jun 03 04:29 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentJun 02 '25Sale77.402,570198,91150,356Jun 02 05:01 PM
BOBO DONALD E JROfficerJun 02 '25Proposed Sale77.402,570198,911Jun 02 04:03 PM
Zovighian Bernard JOfficerMay 30 '25Proposed Sale77.2116,0991,243,064May 30 04:31 PM
Chopra DaveenCVP, TMTTMay 22 '25Sale75.081,500112,61233,496May 22 05:08 PM
Chopra DaveenOfficerMay 22 '25Proposed Sale75.071,500112,612May 22 04:01 PM
Lippis Daniel J.CVP, JAPACMay 09 '25Option Exercise45.2833014,94126,946May 09 07:35 PM
Lippis Daniel J.CVP, JAPACMay 09 '25Sale74.4233024,56026,616May 09 07:35 PM
Markowitz WayneGM & SVP, SurgicalMay 07 '25Sale75.0826820,1219,299May 09 07:34 PM
Ullem Scott B.CVP, Chief Financial OfficerMay 09 '25Option Exercise45.2811,250509,36352,348May 09 07:34 PM
Ullem Scott B.CVP, Chief Financial OfficerMay 09 '25Sale74.4011,250837,03541,098May 09 07:34 PM
Lippis Daniel J.OfficerMay 09 '25Proposed Sale74.4233024,560May 09 04:00 PM
Markowitz WayneOfficerMay 07 '25Proposed Sale75.0826820,121May 07 04:48 PM
Zovighian Bernard JCEOMay 05 '25Option Exercise45.287,462337,85565,746May 06 05:13 PM
Zovighian Bernard JCEOMay 05 '25Sale74.915,980447,97758,284May 06 05:13 PM
Zovighian Bernard JOfficerMay 05 '25Proposed Sale74.915,980447,977May 05 04:03 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentApr 14 '25Option Exercise45.289,500430,12956,706Apr 14 06:18 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentApr 14 '25Sale69.819,500663,19647,206Apr 14 06:18 PM
Lippis Daniel J.CVP, JAPACApr 08 '25Option Exercise45.2830013,58323,163Apr 08 05:12 PM
Lippis Daniel J.CVP, JAPACApr 08 '25Sale70.6130021,18322,863Apr 08 05:12 PM
Lippis Daniel J.OfficerApr 08 '25Proposed Sale70.6130021,183Apr 08 04:19 PM
Ullem Scott B.CVP, Chief Financial OfficerMar 26 '25Option Exercise45.2811,250509,36341,637Mar 26 04:45 PM
Ullem Scott B.CVP, Chief Financial OfficerMar 26 '25Sale70.8711,250797,26730,387Mar 26 04:45 PM
Ullem Scott B.OfficerMar 26 '25Proposed Sale70.8722,5001,594,534Mar 26 04:14 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMar 13 '25Option Exercise45.289,500430,12956,436Mar 13 05:41 PM
BOBO DONALD E JRCVP,Strategy/Corp DevelopmentMar 13 '25Sale67.969,500645,62446,936Mar 13 05:41 PM
Zovighian Bernard JCEOMar 10 '25Option Exercise45.287,463337,90066,546Mar 10 07:35 PM
Zovighian Bernard JCEOMar 10 '25Sale69.516,164428,44859,083Mar 10 07:35 PM
Lippis Daniel J.CVP, JAPACMar 10 '25Option Exercise45.2840018,11122,988Mar 10 07:34 PM
Lippis Daniel J.CVP, JAPACMar 10 '25Sale69.4840027,79222,588Mar 10 07:34 PM
Zovighian Bernard JOfficerMar 10 '25Proposed Sale69.516,164428,448Mar 10 04:13 PM
Lippis Daniel J.OfficerMar 10 '25Proposed Sale69.4840027,792Mar 10 04:13 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 28 '25Option Exercise45.2811,250509,36341,637Feb 28 05:05 PM
Ullem Scott B.CVP, Chief Financial OfficerFeb 28 '25Sale70.7811,250796,32730,387Feb 28 05:05 PM
Last Close
Feb 20  •  04:00PM ET
76.00
Dollar change
+0.13
Percentage change
0.17
%
ESTA Establishment Labs Holdings Inc daily Stock Chart
Index- P/E- EPS (ttm)-2.85 Insider Own9.78% Shs Outstand29.06M Perf Week3.35%
Market Cap2.21B Forward P/E- EPS next Y-1.05 Insider Trans-0.74% Shs Float26.23M Perf Month12.26%
Enterprise Value2.40B PEG- EPS next Q-0.22 Inst Own99.93% Short Float15.65% Perf Quarter17.70%
Income-82.98M P/S11.56 EPS this Y37.87% Inst Trans-0.22% Short Ratio8.94 Perf Half Y94.42%
Sales190.97M P/B134.95 EPS next Y43.73% ROA-26.70% Short Interest4.11M Perf YTD4.28%
Book/sh0.56 P/C31.27 EPS next 5Y- ROE-338.19% 52W High78.24 -2.86% Perf Year116.96%
Cash/sh2.43 P/FCF- EPS past 3/5Y-20.52% -10.09% ROIC-31.22% 52W Low26.56 186.20% Perf 3Y7.60%
Dividend Est.- EV/EBITDA- Sales past 3/5Y9.43% 13.14% Gross Margin68.74% Volatility5.64% 5.71% Perf 5Y7.95%
Dividend TTM- EV/Sales12.56 EPS Y/Y TTM-10.41% Oper. Margin-28.14% ATR (14)4.01 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.10 Sales Y/Y TTM24.76% Profit Margin-43.45% RSI (14)62.37 Recom1.22
Dividend Gr. 3/5Y- - Current Ratio3.33 EPS Q/Q36.27% SMA207.44% Beta0.92 Target Price83.44
Payout- Debt/Eq15.96 Sales Q/Q33.70% SMA507.37% Rel Volume1.11 Prev Close75.87
Employees1018 LT Debt/Eq15.25 EarningsFeb 24 BMO SMA20048.42% Avg Volume458.94K Price76.00
IPOJul 19, 2018 Option/ShortYes / Yes EPS/Sales Surpr.24.90% 3.03% Trades Volume510,253 Change0.17%
Date Action Analyst Rating Change Price Target Change
Aug-20-25Initiated Canaccord Genuity Buy $60
May-16-25Initiated BTIG Research Buy $62
May-14-25Upgrade Needham Hold → Buy $48
Apr-14-25Initiated Needham Hold
May-22-24Downgrade Citigroup Buy → Neutral $60
Aug-31-23Initiated JP Morgan Overweight $75
Jun-29-23Initiated Citigroup Buy $79
Oct-14-22Resumed Stephens Overweight $90
Oct-13-22Initiated Mizuho Buy $70
Aug-24-22Initiated B. Riley Securities Buy $107
Feb-18-26 08:00AM
Feb-17-26 10:50AM
Feb-10-26 08:00AM
Feb-03-26 08:46AM
Jan-12-26 08:00AM
07:40AM Loading…
Jan-01-26 07:40AM
Dec-31-25 08:00AM
Dec-30-25 12:45PM
Dec-29-25 08:00AM
Nov-17-25 12:15PM
Nov-07-25 08:00AM
Nov-06-25 02:00PM
Nov-05-25 09:15AM
08:00AM
Nov-04-25 07:59AM
05:40PM Loading…
Oct-22-25 05:40PM
08:00AM
Oct-14-25 08:00AM
Oct-09-25 08:00AM
Aug-08-25 11:02AM
Aug-07-25 09:15AM
08:00AM
Aug-06-25 05:45PM
Jul-31-25 07:40AM
Jul-25-25 08:00AM
Jun-12-25 04:29AM
03:55AM
Jun-11-25 07:07PM
Jun-03-25 04:30PM
May-08-25 10:14AM
03:31AM Loading…
03:31AM
May-07-25 05:10PM
04:04PM
04:00PM
04:00PM
May-01-25 10:01AM
Apr-30-25 10:01AM
Apr-24-25 08:00AM
Apr-21-25 02:51PM
Apr-14-25 09:43AM
Apr-10-25 09:00AM
Mar-20-25 08:00AM
Mar-06-25 12:00PM
Feb-27-25 02:28AM
Feb-26-25 05:10PM
04:00PM
Feb-25-25 10:41AM
08:00AM
Feb-21-25 08:00AM
Feb-18-25 08:00AM
Feb-14-25 08:00AM
Feb-06-25 09:35AM
Jan-13-25 08:00AM
Jan-07-25 08:00AM
Dec-10-24 10:56PM
Nov-11-24 08:00AM
Nov-09-24 07:35AM
Nov-08-24 08:01AM
Nov-07-24 05:20PM
05:20PM
04:00PM
Nov-06-24 07:21AM
Oct-31-24 08:00AM
Oct-24-24 08:00AM
Oct-15-24 08:00AM
Oct-02-24 08:00AM
Sep-30-24 06:00AM
Sep-27-24 04:12AM
Sep-26-24 05:02PM
Aug-26-24 06:18AM
Aug-09-24 06:43AM
Aug-06-24 05:15PM
04:00PM
Jul-24-24 08:00AM
Jun-25-24 04:33AM
Jun-17-24 07:39AM
May-23-24 08:00AM
May-10-24 05:29PM
01:37PM
May-09-24 06:50AM
May-08-24 09:00PM
05:10PM
04:00PM
May-02-24 08:30AM
May-01-24 08:30AM
Apr-24-24 08:30AM
Apr-17-24 08:30AM
Feb-29-24 10:06AM
Feb-28-24 05:30PM
04:55PM
04:00PM
07:39AM
Feb-23-24 08:00AM
Feb-22-24 08:00AM
Feb-21-24 10:00AM
Feb-14-24 08:00AM
Feb-07-24 04:42AM
Jan-22-24 08:00AM
Jan-09-24 08:06AM
Jan-02-24 08:00AM
Establishment Labs Holdings, Inc. engages in the manufacturing and marketing of medical devices for aesthetic and reconstructive plastic surgery. Its brands include Motiva Implants, SilkSurface, SmoothSilk, VelvetSurface, ProgressiveGel, TrueMonobloc, BluSeal, Divina, Ergonomix, Ergomonix2, Ergonomix2 Diamond, Mia Femtech, MotivaImagine, GEM, Zen, Preserve, etc. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JW Asset Management, LLC10% OwnerNov 10 '25Sale67.0711,000737,7703,061,694Nov 12 04:01 PM
JW Asset Management, LLC10% OwnerNov 07 '25Sale65.092,500162,7253,072,694Nov 12 09:56 AM
JW Asset Management, LLC10% OwnerNov 06 '25Sale65.007,591493,4153,075,194Nov 10 04:01 PM
LEWIN NICHOLAS SHERIDANDirectorAug 14 '25Buy37.852,60098,41019,090Aug 14 10:58 AM
LEWIN NICHOLAS SHERIDANDirectorAug 13 '25Buy34.302,30078,88016,490Aug 13 11:02 AM
Caldini FilippoChief Executive OfficerAug 11 '25Buy35.202,850100,32035,245Aug 11 01:32 PM
JW Asset Management, LLC10% OwnerJul 01 '25Sale44.389,700430,4863,082,785Jul 02 04:01 PM
Last Close
Feb 20  •  04:00PM ET
0.4251
Dollar change
-0.0949
Percentage change
-18.25
%
LFWD Lifeward Ltd daily Stock Chart
Index- P/E- EPS (ttm)-2.98 Insider Own1.77% Shs Outstand18.29M Perf Week-16.65%
Market Cap7.78M Forward P/E- EPS next Y-0.23 Insider Trans-0.49% Shs Float17.97M Perf Month-39.27%
Enterprise Value5.83M PEG- EPS next Q-0.08 Inst Own3.74% Short Float11.02% Perf Quarter-29.89%
Income-29.84M P/S0.32 EPS this Y73.27% Inst Trans-0.61% Short Ratio4.05 Perf Half Y-30.43%
Sales24.50M P/B0.56 EPS next Y74.16% ROA-86.58% Short Interest1.98M Perf YTD-26.27%
Book/sh0.76 P/C3.55 EPS next 5Y80.42% ROE-127.95% 52W High2.95 -85.59% Perf Year-76.90%
Cash/sh0.12 P/FCF- EPS past 3/5Y-21.43% 29.33% ROIC-232.38% 52W Low0.50 -14.98% Perf 3Y-92.31%
Dividend Est.- EV/EBITDA- Sales past 3/5Y62.63% 39.41% Gross Margin37.49% Volatility11.09% 7.92% Perf 5Y-98.53%
Dividend TTM- EV/Sales0.24 EPS Y/Y TTM-32.93% Oper. Margin-70.24% ATR (14)0.05 Perf 10Y-99.98%
Dividend Ex-Date- Quick Ratio1.13 Sales Y/Y TTM-2.02% Profit Margin-121.82% RSI (14)25.42 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.92 EPS Q/Q43.81% SMA20-25.16% Beta0.15 Target Price7.25
Payout- Debt/Eq0.02 Sales Q/Q1.09% SMA50-31.78% Rel Volume2.19 Prev Close0.52
Employees80 LT Debt/Eq0.01 EarningsNov 14 BMO SMA200-43.04% Avg Volume489.24K Price0.43
IPOSep 12, 2014 Option/ShortYes / Yes EPS/Sales Surpr.5.00% -1.84% Trades Volume1,072,744 Change-18.25%
Date Action Analyst Rating Change Price Target Change
Feb-10-25Initiated Laidlaw Buy $10
Apr-03-17Downgrade Barclays Equal Weight → Underweight $2.50 → $1.50
Dec-16-16Initiated Oppenheimer Outperform
Jul-15-16Initiated Piper Jaffray Overweight $10
May-22-15Upgrade Canaccord Genuity Hold → Buy $11 → $17
May-08-15Reiterated Barclays Equal Weight $20 → $13
Oct-07-14Initiated Barclays Equal Weight $28
Feb-20-26 08:00AM
Feb-17-26 08:00AM
Jan-13-26 08:00AM
Dec-19-25 04:05PM
Dec-17-25 08:00AM
08:00AM Loading…
Dec-03-25 08:00AM
Nov-17-25 08:00AM
Nov-14-25 04:01PM
08:11AM
08:00AM
Nov-13-25 07:31AM
Nov-10-25 07:00AM
Sep-09-25 08:45AM
08:30AM
Sep-08-25 08:30AM
09:10AM Loading…
Aug-14-25 09:10AM
08:06AM
08:00AM
Aug-13-25 08:00AM
Aug-12-25 06:00PM
Aug-07-25 05:30PM
05:25PM
Aug-06-25 10:50AM
Aug-05-25 06:20PM
Aug-04-25 08:30AM
Jul-07-25 11:00AM
Jun-26-25 04:15PM
09:15AM
Jun-25-25 09:10AM
Jun-24-25 04:05PM
08:00AM Loading…
May-20-25 08:00AM
May-19-25 08:30AM
06:00AM
May-16-25 03:08AM
May-15-25 09:15AM
08:00AM
May-08-25 08:30AM
May-07-25 04:30PM
Apr-29-25 08:30AM
Apr-24-25 08:30AM
Apr-16-25 07:13AM
Apr-15-25 08:15AM
Mar-23-25 08:40AM
Mar-13-25 09:15AM
Mar-08-25 02:03AM
Mar-07-25 08:00AM
Mar-06-25 08:00AM
Mar-05-25 08:00AM
Feb-28-25 08:00AM
Feb-19-25 09:10AM
Feb-06-25 08:20AM
Feb-05-25 08:00AM
Feb-04-25 08:00AM
Jan-13-25 08:30AM
07:45AM
Jan-08-25 04:15PM
Jan-07-25 08:05AM
Dec-27-24 05:49PM
Nov-19-24 08:30AM
Nov-13-24 02:08AM
Nov-12-24 08:00AM
Nov-07-24 04:05PM
Nov-05-24 04:38PM
Nov-04-24 08:00AM
Oct-24-24 04:30PM
Sep-24-24 05:00PM
Sep-12-24 08:30AM
Sep-10-24 08:30AM
Sep-05-24 08:30AM
Sep-04-24 04:15PM
Aug-15-24 08:00AM
Aug-08-24 04:15PM
Jul-02-24 04:30PM
Jun-26-24 08:30AM
Jun-11-24 10:50AM
Jun-04-24 04:30PM
May-28-24 03:32AM
May-16-24 08:18AM
May-15-24 09:10AM
08:00AM
May-14-24 12:00PM
May-07-24 04:30PM
May-02-24 10:01AM
Apr-26-24 10:19AM
Apr-23-24 09:55AM
Apr-19-24 08:30AM
Apr-12-24 08:30AM
Apr-01-24 04:30PM
Mar-24-24 03:54PM
Mar-22-24 08:30AM
Mar-13-24 11:45AM
Mar-08-24 08:30AM
Mar-01-24 12:00PM
08:45AM
Feb-27-24 09:15AM
08:00AM
Feb-20-24 08:30AM
Jan-29-24 08:00AM
Jan-28-24 08:07PM
Jan-16-24 08:47AM
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lynch JeannineVP of Market Access & StrategySep 02 '25Sale0.641,5911,01846,067Sep 04 05:07 PM
Jasinski Lawrence JChief Executive OfficerMay 21 '25Sale1.261,9092,40598,728May 22 04:29 PM
Last Close
Feb 20  •  04:00PM ET
9.56
Dollar change
+0.16
Percentage change
1.70
%
LAKE Lakeland Industries, Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-4.46 Insider Own14.25% Shs Outstand9.80M Perf Week-2.94%
Market Cap93.75M Forward P/E21.01 EPS next Y0.46 Insider Trans-0.03% Shs Float8.41M Perf Month4.71%
Enterprise Value128.77M PEG- EPS next Q-0.11 Inst Own82.76% Short Float17.93% Perf Quarter-34.07%
Income-37.54M P/S0.48 EPS this Y13.79% Inst Trans2.89% Short Ratio6.13 Perf Half Y-37.15%
Sales193.46M P/B0.70 EPS next Y121.72% ROA-17.79% Short Interest1.51M Perf YTD8.14%
Book/sh13.73 P/C5.45 EPS next 5Y- ROE-28.97% 52W High25.53 -62.55% Perf Year-61.94%
Cash/sh1.75 P/FCF- EPS past 3/5Y- - ROIC-20.67% 52W Low7.77 23.04% Perf 3Y-40.25%
Dividend Est.0.09 (0.94%) EV/EBITDA- Sales past 3/5Y12.20% 9.17% Gross Margin34.78% Volatility3.38% 4.10% Perf 5Y-72.92%
Dividend TTM0.12 (1.26%) EV/Sales0.67 EPS Y/Y TTM-5275.12% Oper. Margin-2.17% ATR (14)0.41 Perf 10Y-22.09%
Dividend Ex-DateNov 17, 2025 Quick Ratio1.48 Sales Y/Y TTM27.42% Profit Margin-19.40% RSI (14)48.55 Recom1.50
Dividend Gr. 3/5Y- - Current Ratio3.83 EPS Q/Q-14707.14% SMA200.24% Beta1.28 Target Price16.50
Payout- Debt/Eq0.39 Sales Q/Q3.99% SMA503.47% Rel Volume0.28 Prev Close9.40
Employees2100 LT Debt/Eq0.35 EarningsDec 09 AMC SMA200-31.29% Avg Volume245.93K Price9.56
IPOSep 09, 1986 Option/ShortYes / Yes EPS/Sales Surpr.-736.89% -15.99% Trades Volume69,039 Change1.70%
Date Action Analyst Rating Change Price Target Change
Dec-10-25Downgrade DA Davidson Buy → Neutral $14
Mar-26-25Initiated DA Davidson Buy $28
Mar-11-25Initiated Lake Street Buy $30
Apr-24-24Initiated Maxim Group Buy $22
Jun-09-20Initiated The Benchmark Company Buy
Apr-15-20Resumed ROTH Capital Buy $18.50
Aug-23-17Initiated ROTH Capital Buy $18
Feb-10-16Initiated Singular Research Buy $17.50
Apr-13-07Reiterated Friedman Billings Mkt Perform $16 → $14
Feb-19-26 08:31AM
Feb-18-26 08:31AM
Feb-17-26 08:31AM
Feb-12-26 08:31AM
Feb-05-26 11:49AM
08:46AM Loading…
Feb-04-26 08:46AM
Feb-03-26 08:31AM
Jan-28-26 08:31AM
Jan-26-26 08:31AM
Jan-13-26 08:31AM
Dec-18-25 08:31AM
Dec-10-25 12:00AM
Dec-09-25 06:30PM
05:27PM
04:01PM
08:31AM Loading…
Dec-04-25 08:31AM
07:10AM
Dec-03-25 08:31AM
Nov-25-25 08:31AM
Nov-19-25 08:31AM
Nov-17-25 08:40AM
Nov-12-25 05:25PM
Nov-10-25 05:25PM
12:55PM
Nov-06-25 06:00PM
09:52AM
Nov-03-25 04:05PM
Oct-30-25 07:09AM
04:38AM
Oct-02-25 09:55AM
04:01PM Loading…
Sep-15-25 04:01PM
09:15AM
08:31AM
Sep-10-25 03:03AM
Sep-09-25 05:15PM
04:10PM
04:01PM
Sep-08-25 09:17AM
Sep-03-25 08:31AM
Aug-27-25 08:31AM
Aug-26-25 08:31AM
Aug-12-25 05:15PM
Aug-07-25 06:20PM
Aug-04-25 04:29AM
Aug-01-25 04:05PM
Jul-24-25 08:30AM
Jul-23-25 08:31AM
Jul-21-25 08:31AM
Jun-30-25 01:00PM
Jun-12-25 08:31AM
Jun-10-25 09:30AM
03:01AM
Jun-09-25 04:01PM
Jun-03-25 07:10AM
May-30-25 08:31AM
May-28-25 07:40AM
May-22-25 04:01PM
May-21-25 12:55PM
May-13-25 05:25PM
May-01-25 04:05PM
Apr-26-25 05:00AM
Apr-10-25 08:31AM
03:01AM
Apr-09-25 07:39PM
05:15PM
04:21PM
04:01PM
Apr-01-25 10:01AM
Mar-27-25 08:31AM
Mar-04-25 08:31AM
Feb-17-25 04:35PM
Feb-13-25 08:31AM
Feb-11-25 08:31AM
Feb-05-25 08:46AM
Feb-04-25 08:31AM
Feb-03-25 04:05PM
Jan-29-25 08:45AM
08:40AM
Jan-28-25 08:31AM
Jan-24-25 04:01PM
Jan-23-25 08:30AM
Jan-22-25 04:20PM
Dec-16-24 04:05PM
Dec-06-24 02:03AM
Dec-05-24 05:40PM
04:40PM
04:22PM
Dec-04-24 07:03AM
Dec-03-24 04:01PM
Nov-21-24 08:31AM
Nov-01-24 04:31PM
Oct-16-24 08:31AM
Oct-15-24 05:02PM
Sep-06-24 05:00AM
Sep-04-24 05:45PM
04:43PM
04:35PM
09:05AM
Sep-03-24 09:04AM
Aug-22-24 10:33AM
Lakeland Industries, Inc. engages in the manufacture and sale of safety garments and accessories for the industrial and public protective clothing market. It operates through the Domestic and International geographical segments. The firm's products include disposable protective clothing, chemical protective clothing, woven protective clothing, fire protective gear, heat protective clothing, reflective protective clothing, hand and arm protection, arc or fire-retardant rated rainwear, and fire-retardant protective clothing. The company was founded in April 1982 and is headquartered in Huntsville, AL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Stokes CameronSee RemarksJan 13 '26Buy9.434504,2444,758Jan 15 01:54 PM
Hui AnChief Operating OfficerJan 09 '26Buy8.972,00017,94072,850Jan 12 12:38 PM
Swinea James Calven Jr.Interim CFOJan 09 '26Buy8.711,0008,7107,305Jan 09 12:46 PM
Jenkins James M.President, CEO & Exec. ChairJan 05 '26Buy8.881,12710,00394,565Jan 05 12:40 PM
Phillips Barry GChief Revenue Officer - FireDec 23 '25Buy8.711,25010,88818,802Dec 29 12:56 PM
Yartz Laurel A.Chief Human Resources OfficerDec 22 '25Buy8.151,35011,00015,826Dec 23 10:48 AM
Shannon Roger DOfficerDec 16 '25Proposed Sale8.068,86971,484Dec 19 03:39 PM
Jenkins James M.President, CEO & Exec. ChairDec 19 '25Buy7.921,26510,01993,438Dec 19 03:29 PM
Shannon Roger DChief Financial OfficerDec 16 '25Sale8.068,86971,48436,026Dec 18 02:09 PM
Jenkins James M.President, CEO & Exec. ChairJun 18 '25Buy13.141,00013,14097,272Jun 20 12:44 PM
Yartz Laurel A.Chief Human Resources OfficerApr 22 '25Buy15.971,00015,97014,721Apr 24 02:17 PM
Jenkins James M.President, CEO & Exec. ChairApr 22 '25Buy15.931,56524,93097,984Apr 24 02:17 PM
Last Close
Feb 20  •  04:00PM ET
44.26
Dollar change
+0.89
Percentage change
2.05
%
CDRE Cadre Holdings Inc daily Stock Chart
IndexRUT P/E39.95 EPS (ttm)1.11 Insider Own30.68% Shs Outstand40.68M Perf Week7.30%
Market Cap1.80B Forward P/E30.36 EPS next Y1.46 Insider Trans-10.27% Shs Float28.19M Perf Month-0.90%
Enterprise Value1.98B PEG1.41 EPS next Q0.40 Inst Own78.26% Short Float8.08% Perf Quarter10.07%
Income45.38M P/S2.91 EPS this Y32.44% Inst Trans9.17% Short Ratio10.11 Perf Half Y51.26%
Sales619.07M P/B5.29 EPS next Y22.32% ROA6.44% Short Interest2.28M Perf YTD8.37%
Book/sh8.37 P/C11.93 EPS next 5Y21.58% ROE14.17% 52W High46.64 -5.10% Perf Year26.64%
Cash/sh3.71 P/FCF29.36 EPS past 3/5Y34.50% - ROIC6.97% 52W Low27.07 63.48% Perf 3Y86.28%
Dividend Est.0.38 (0.86%) EV/EBITDA19.25 Sales past 3/5Y9.93% 6.17% Gross Margin41.91% Volatility3.39% 3.89% Perf 5Y-
Dividend TTM0.39 (0.87%) EV/Sales3.20 EPS Y/Y TTM33.38% Oper. Margin13.72% ATR (14)1.57 Perf 10Y-
Dividend Ex-DateJan 30, 2026 Quick Ratio2.58 Sales Y/Y TTM19.94% Profit Margin7.33% RSI (14)61.65 Recom1.00
Dividend Gr. 3/5Y63.55% - Current Ratio3.64 EPS Q/Q198.99% SMA205.84% Beta1.34 Target Price54.00
Payout39.07% Debt/Eq0.98 Sales Q/Q42.47% SMA504.94% Rel Volume0.61 Prev Close43.37
Employees2284 LT Debt/Eq0.91 EarningsNov 04 AMC SMA20018.83% Avg Volume225.25K Price44.26
IPONov 04, 2021 Option/ShortYes / Yes EPS/Sales Surpr.3.29% -1.94% Trades Volume138,522 Change2.05%
Date Action Analyst Rating Change Price Target Change
Aug-13-25Downgrade BofA Securities Neutral → Underperform $26
Jun-13-25Downgrade BofA Securities Buy → Neutral $38
Feb-21-24Reiterated ROTH MKM Buy $32 → $38
Jan-22-24Downgrade Raymond James Outperform → Mkt Perform
Sep-06-22Initiated BofA Securities Buy $30
Aug-31-22Initiated Jefferies Buy $32
Feb-19-26 01:12PM
Feb-16-26 11:31PM
Feb-06-26 04:40PM
Feb-02-26 08:30AM
Jan-26-26 09:20AM
08:28AM Loading…
Jan-23-26 08:28AM
Jan-20-26 04:42PM
Jan-06-26 04:15PM
Jan-04-26 11:36PM
Jan-01-26 11:33PM
Dec-21-25 10:56AM
Dec-15-25 04:06PM
Dec-09-25 11:02PM
Dec-01-25 08:24PM
Nov-27-25 10:33PM
04:15PM Loading…
Nov-19-25 04:15PM
09:28AM
Nov-16-25 11:41PM
Nov-11-25 12:31AM
Nov-10-25 08:02PM
Nov-05-25 05:05PM
Nov-04-25 07:30PM
06:45PM
05:44PM
04:15PM
07:55AM
Nov-03-25 07:38AM
Nov-02-25 10:14PM
Oct-30-25 07:55AM
Oct-29-25 06:00AM
12:02AM Loading…
Oct-23-25 12:02AM
Oct-22-25 04:15PM
Oct-21-25 04:15PM
Oct-01-25 11:35PM
Sep-23-25 12:56PM
Sep-22-25 04:15PM
Sep-09-25 02:01PM
Aug-22-25 12:42AM
Aug-21-25 04:15PM
Aug-14-25 05:15PM
Aug-13-25 12:39AM
Aug-12-25 03:13AM
03:11AM
Aug-05-25 07:05PM
05:22PM
04:15PM
09:55AM
Aug-04-25 09:41AM
Aug-03-25 11:05PM
Jul-31-25 09:00AM
Jul-24-25 07:10AM
Jul-23-25 04:15PM
Jul-22-25 04:15PM
Jul-21-25 07:59AM
Jul-11-25 12:04AM
Jun-28-25 12:31PM
Jun-27-25 05:31AM
Jun-04-25 11:37PM
May-23-25 12:31AM
May-21-25 12:34AM
May-08-25 03:23AM
02:53AM
May-07-25 11:52AM
11:50AM
May-06-25 05:45PM
04:15PM
May-05-25 09:50AM
Apr-27-25 04:50PM
Apr-24-25 08:10AM
Apr-23-25 04:15PM
Apr-22-25 04:16PM
04:15PM
Apr-12-25 11:15AM
Apr-11-25 05:07AM
Mar-29-25 09:58PM
Mar-28-25 03:33PM
Mar-24-25 04:37PM
Mar-21-25 05:08AM
Mar-20-25 11:40AM
Mar-13-25 03:06AM
12:43AM
Mar-11-25 05:25PM
05:00PM
04:15PM
Mar-10-25 08:02AM
Feb-26-25 04:15PM
09:40AM
Feb-21-25 06:28AM
Feb-07-25 09:40AM
Jan-23-25 10:18AM
Jan-22-25 09:40AM
Jan-21-25 04:15PM
04:08AM
Jan-15-25 07:53PM
Jan-13-25 04:15PM
Dec-23-24 09:13AM
Nov-22-24 03:39AM
Nov-20-24 09:19AM
Nov-07-24 08:00AM
Nov-06-24 06:15PM
Cadre Holdings, Inc. engages in the manufacture and distribution of safety and survivability products, and other related products for the law enforcement, first responder and military markets. It operates through the Product and Distribution segments. The Product segment consists of components that manufacture and sell products. The Distribution segment refers to business that serves as a one-stop shop for law enforcement agencies that sells goods produced by the product segment, as well as other third-party products. The company was founded on April 12, 2012 and is headquartered in Jacksonville, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Browers BlaineCHIEF FINANCIAL OFFICERDec 12 '25Sale43.7920,435894,84963,142Dec 16 04:15 PM
Blaine BrowersOfficerDec 12 '25Proposed Sale44.0020,435899,140Dec 12 05:04 PM
Williams BradPRESIDENTDec 10 '25Sale42.9924,0001,031,76054,719Dec 12 04:15 PM
Brad WilliamsOfficerDec 10 '25Proposed Sale42.9724,0001,031,309Dec 10 05:39 PM
KANDERS WARREN BCEO AND CHAIRMANNov 17 '25Sale39.001,257,03849,024,4821,546Nov 19 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANNov 17 '25Sale39.0086,9033,389,21710,129,289Nov 19 04:15 PM
Warren B. KandersOfficerNov 17 '25Proposed Sale42.091,343,94156,566,477Nov 17 06:41 PM
Williams BradPRESIDENTNov 13 '25Sale43.6227,3701,193,87978,719Nov 17 04:15 PM
Brad WilliamsOfficerNov 13 '25Proposed Sale43.6127,3701,193,605Nov 13 05:48 PM
Williams BradPRESIDENTOct 24 '25Sale43.004,132177,676106,089Oct 28 04:15 PM
Williams BradOfficerOct 24 '25Proposed Sale43.004,132177,676Oct 24 04:02 PM
Williams BradPRESIDENTOct 14 '25Sale40.004,132165,280110,221Oct 16 04:15 PM
Williams BradOfficerOct 14 '25Proposed Sale40.004,132165,280Oct 14 04:04 PM
Williams BradPRESIDENTSep 23 '25Sale37.004,132152,884114,353Sep 25 04:15 PM
Williams BradOfficerSep 23 '25Proposed Sale37.004,132152,884Sep 23 04:30 PM
KANDERS WARREN BCEO AND CHAIRMANJun 23 '25Sale32.7825,000819,50010,216,192Jun 24 04:35 PM
KANDERS WARREN BCEO AND CHAIRMANJun 18 '25Sale33.9550,0001,697,50010,291,192Jun 23 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANJun 20 '25Sale33.0150,0001,650,50010,241,192Jun 23 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANJun 03 '25Sale33.51100,0003,351,00010,366,192Jun 05 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANJun 04 '25Sale33.9925,000849,75010,341,192Jun 05 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANMay 30 '25Sale32.7550,0001,637,50010,466,192Jun 03 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANMay 27 '25Sale33.1150,0001,655,50010,566,192May 29 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANMay 28 '25Sale32.7050,0001,635,00010,516,192May 29 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANMay 22 '25Sale33.1950,0001,659,50010,666,192May 27 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANMay 23 '25Sale32.6550,0001,632,50010,616,192May 27 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANMay 20 '25Sale34.86100,0003,486,00010,716,192May 22 04:15 PM
KANDERS WARREN BOfficerMay 20 '25Proposed Sale36.00750,00027,000,000May 20 04:33 PM
KANDERS WARREN BCEO AND CHAIRMANMar 20 '25Sale31.8850,0001,594,00010,866,192Mar 24 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANMar 21 '25Sale30.9850,0001,549,00010,816,192Mar 24 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANMar 19 '25Sale31.73100,0003,173,00010,916,192Mar 20 04:16 PM
KANDERS WARREN BCEO AND CHAIRMANMar 18 '25Sale32.2050,0001,610,00011,016,192Mar 20 04:16 PM
KANDERS WARREN BCEO AND CHAIRMANMar 14 '25Sale33.86100,0003,386,00011,166,192Mar 18 04:15 PM
KANDERS WARREN BCEO AND CHAIRMANMar 17 '25Sale32.38100,0003,238,00011,066,192Mar 18 04:15 PM
KANDERS WARREN BOfficerMar 14 '25Proposed Sale33.86750,00025,395,000Mar 14 04:29 PM
Last Close
Feb 20  •  04:00PM ET
250.65
Dollar change
-0.53
Percentage change
-0.21
%
STE Steris Plc daily Stock Chart
IndexS&P 500 P/E34.68 EPS (ttm)7.23 Insider Own0.33% Shs Outstand98.10M Perf Week2.63%
Market Cap24.58B Forward P/E22.54 EPS next Y11.12 Insider Trans-8.07% Shs Float97.75M Perf Month-4.03%
Enterprise Value26.23B PEG2.34 EPS next Q2.85 Inst Own96.25% Short Float1.60% Perf Quarter-2.47%
Income713.65M P/S4.22 EPS this Y9.30% Inst Trans-2.02% Short Ratio2.30 Perf Half Y0.44%
Sales5.83B P/B3.44 EPS next Y9.06% ROA6.88% Short Interest1.56M Perf YTD-1.13%
Book/sh72.93 P/C58.02 EPS next 5Y9.62% ROE10.44% 52W High269.44 -6.97% Perf Year13.52%
Cash/sh4.32 P/FCF26.80 EPS past 3/5Y36.77% 5.92% ROIC7.78% 52W Low204.90 22.33% Perf 3Y32.16%
Dividend Est.2.46 (0.98%) EV/EBITDA16.68 Sales past 3/5Y5.99% 12.49% Gross Margin44.33% Volatility2.22% 2.54% Perf 5Y40.24%
Dividend TTM2.46 (0.98%) EV/Sales4.50 EPS Y/Y TTM53.16% Oper. Margin18.65% ATR (14)6.84 Perf 10Y293.98%
Dividend Ex-DateFeb 17, 2026 Quick Ratio1.75 Sales Y/Y TTM7.96% Profit Margin12.25% RSI (14)46.73 Recom1.82
Dividend Gr. 3/5Y9.68% 8.99% Current Ratio2.48 EPS Q/Q11.55% SMA20-1.31% Beta1.05 Target Price288.43
Payout35.14% Debt/Eq0.29 Sales Q/Q9.17% SMA50-2.07% Rel Volume1.58 Prev Close251.18
Employees17787 LT Debt/Eq0.28 EarningsFeb 04 AMC SMA2001.82% Avg Volume677.87K Price250.65
IPOJun 01, 1992 Option/ShortYes / Yes EPS/Sales Surpr.-0.10% 1.03% Trades Volume1,074,127 Change-0.21%
Date Action Analyst Rating Change Price Target Change
Jul-15-25Upgrade Morgan Stanley Equal-Weight → Overweight $276
May-29-25Initiated Jefferies Hold $263
Oct-24-24Upgrade Piper Sandler Neutral → Overweight $230 → $260
Feb-06-24Resumed KeyBanc Capital Markets Overweight $253
May-30-23Initiated Morgan Stanley Equal-Weight $206
Apr-14-23Downgrade Piper Sandler Overweight → Neutral $215 → $197
Sep-23-22Downgrade Needham Buy → Hold
Jul-14-22Initiated Piper Sandler Overweight $240
Apr-07-22Initiated Wolfe Research Outperform $275
May-26-21Upgrade Needham Hold → Buy $233
Feb-20-26 07:27AM
Feb-15-26 06:53AM
Feb-11-26 12:35AM
Feb-09-26 09:15AM
Feb-07-26 01:13AM
07:46PM Loading…
Feb-05-26 07:46PM
04:00PM
09:25AM
Feb-04-26 06:00PM
05:40PM
04:54PM
04:39PM
04:30PM
11:55AM
Feb-03-26 10:29AM
08:29AM Loading…
08:29AM
Feb-02-26 10:17PM
09:51AM
Jan-30-26 12:07PM
Jan-29-26 12:47PM
Jan-28-26 04:30PM
12:35PM
12:31PM
07:26AM
Jan-27-26 11:47AM
Jan-23-26 11:43AM
Jan-22-26 12:32PM
Jan-21-26 04:30PM
10:49AM
07:58AM
04:30PM Loading…
Jan-20-26 04:30PM
Jan-19-26 12:34PM
12:31PM
Jan-16-26 09:27AM
Jan-15-26 10:37AM
10:35AM
08:24AM
Jan-14-26 10:31PM
10:48AM
10:44AM
Jan-12-26 08:09AM
Jan-09-26 09:08AM
Jan-08-26 06:02AM
Dec-26-25 12:00PM
Dec-16-25 09:45AM
Dec-10-25 07:57AM
Dec-09-25 11:47AM
11:32AM
Dec-05-25 11:30AM
Dec-04-25 08:27AM
Dec-03-25 11:03PM
Nov-20-25 12:00PM
09:11AM
Nov-10-25 09:15AM
Nov-07-25 09:37PM
Nov-06-25 04:15PM
11:37AM
08:29AM
Nov-05-25 07:00PM
05:50PM
05:04PM
04:51PM
04:30PM
Nov-04-25 06:05PM
09:15AM
Nov-03-25 10:04PM
Oct-30-25 05:10PM
Oct-29-25 04:30PM
Oct-23-25 11:56AM
12:01AM
Oct-22-25 08:40AM
04:39AM
Oct-21-25 04:30PM
Oct-08-25 11:43AM
Sep-23-25 08:19AM
Sep-17-25 07:18AM
Sep-16-25 09:32AM
Sep-15-25 09:45AM
Sep-12-25 12:41AM
Sep-03-25 11:31PM
Sep-02-25 04:26PM
Aug-27-25 09:45AM
09:40AM
Aug-13-25 01:38AM
12:30AM
Aug-12-25 12:30PM
03:16AM
Aug-11-25 03:54PM
09:45AM
09:15AM
Aug-09-25 11:59PM
Aug-07-25 08:18AM
Aug-06-25 07:51PM
06:30PM
05:45PM
04:39PM
04:31PM
04:30PM
Aug-05-25 06:16AM
Aug-04-25 11:04PM
STERIS Plc engages in the provision of healthcare and life science products and service solutions. It operates through the following segments: Healthcare, Life Sciences, Applied Sterilization Technologies, and Dental. The Healthcare segment provides a comprehensive offering for healthcare providers worldwide, focused on sterile processing departments and procedural centers, such as operating rooms and endoscopy suites. The Life Sciences segment designs, manufactures, and sells consumable products, equipment maintenance, specialty services, and capital equipment. The Applied Sterilization Technologies segment is involved in contract sterilization and testing services for medical device and pharmaceutical manufacturers. The Dental segment offers a comprehensive offering for dental practitioners and dental schools, offering instruments, infection prevention consumables and instrument management systems. The company was founded in 1985 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Madsen JuliaSr. VP and GM, Life SciencesNov 21 '25Option Exercise128.225,008642,13913,582Nov 25 04:39 PM
Madsen JuliaSr. VP and GM, Life SciencesNov 21 '25Sale262.005,0081,312,09610,710Nov 25 04:39 PM
Madsen JuliaOfficerNov 21 '25Proposed Sale262.005,0081,312,096Nov 21 04:51 PM
Tamaro RenatoV.P. & Corporate TreasurerNov 18 '25Option Exercise182.223,536644,33010,731Nov 20 04:31 PM
Tamaro RenatoV.P. & Corporate TreasurerNov 18 '25Sale257.555,0361,297,0405,695Nov 20 04:31 PM
Tamaro RenatoOfficerNov 18 '25Proposed Sale257.555,0361,297,033Nov 18 04:46 PM
Zangerle John AdamSr. VP, Gen Counsel, and Sec.Nov 11 '25Option Exercise69.7215,0001,045,80048,669Nov 13 04:34 PM
Zangerle John AdamSr. VP, Gen Counsel, and Sec.Nov 11 '25Sale265.1415,0003,977,10033,669Nov 13 04:34 PM
Zangerle John AdamOfficerNov 11 '25Proposed Sale265.1415,0003,977,050Nov 12 01:26 PM
Carestio Daniel APresident and CEOOct 06 '25Sale241.8215938,44951,096Oct 08 04:34 PM
Carestio Daniel AOfficerOct 06 '25Proposed Sale241.8215938,449Oct 06 04:02 PM
Tamaro RenatoV.P. & Corporate TreasurerAug 20 '25Option Exercise147.053,204471,14810,425Aug 22 04:30 PM
Tamaro RenatoV.P. & Corporate TreasurerAug 20 '25Sale249.243,204798,5657,221Aug 22 04:30 PM
Tamaro RenatoOfficerAug 20 '25Proposed Sale249.243,204798,560Aug 20 05:19 PM
Breeden Richard CDirectorAug 13 '25Option Exercise64.054,110263,24636,664Aug 15 04:31 PM
Sohi MohsenDirectorAug 11 '25Option Exercise64.054,110263,24626,471Aug 12 05:28 PM
Sohi MohsenDirectorAug 11 '25Sale241.964,110994,45622,361Aug 12 05:28 PM
FELDMANN CYNTHIA LDirectorAug 11 '25Option Exercise0.003,49504,200Aug 12 05:25 PM
FELDMANN CYNTHIA LDirectorAug 11 '25Sale241.563,495844,252705Aug 12 05:25 PM
Burton Karen LVP & CAOAug 11 '25Option Exercise114.227,900902,33813,894Aug 12 05:20 PM
Burton Karen LVP & CAOAug 11 '25Sale241.737,9001,909,6675,994Aug 12 05:20 PM
KOSECOFF JACQUELINE BDirectorAug 12 '25Proposed Sale241.763,781914,084Aug 12 04:59 PM
KOSECOFF JACQUELINE BDirectorAug 11 '25Proposed Sale241.744,110993,562Aug 11 05:10 PM
Sohi MohsenDirectorAug 11 '25Proposed Sale241.964,110994,450Aug 11 05:09 PM
FELDMANN CYNTHIA LDirectorAug 11 '25Proposed Sale241.563,495844,249Aug 11 05:08 PM
Burton Karen LOfficerAug 11 '25Proposed Sale241.737,9001,909,646Aug 11 05:07 PM
Zangerle John AdamSr. VP, Gen Counsel, and Sec.Jun 13 '25Sale241.451,978477,58133,760Jun 17 04:34 PM
Zangerle John AdamOfficerJun 13 '25Proposed Sale241.451,978477,580Jun 13 04:06 PM
Carestio Daniel APresident and CEOJun 05 '25Sale242.5617,6264,275,33851,385Jun 06 04:30 PM
Carestio Daniel AOfficerJun 05 '25Proposed Sale242.5617,6264,275,316Jun 05 04:48 PM
Majors Cary LSVP and President, HealthcareMay 20 '25Option Exercise147.0512,8281,886,35724,200May 22 04:31 PM
Majors Cary LSVP and President, HealthcareMay 20 '25Sale250.0812,8283,208,02611,372May 22 04:31 PM
Majors Cary LOfficerMay 20 '25Proposed Sale250.0812,8283,208,053May 20 04:10 PM
Last Close
Feb 20  •  04:00PM ET
98.75
Dollar change
-0.50
Percentage change
-0.50
%
ZBH Zimmer Biomet Holdings Inc daily Stock Chart
IndexS&P 500 P/E27.84 EPS (ttm)3.55 Insider Own0.14% Shs Outstand198.18M Perf Week3.75%
Market Cap19.57B Forward P/E10.97 EPS next Y9.00 Insider Trans-1.32% Shs Float197.90M Perf Month14.10%
Enterprise Value26.74B PEG2.12 EPS next Q1.86 Inst Own101.55% Short Float4.95% Perf Quarter10.86%
Income705.00M P/S2.38 EPS this Y2.46% Inst Trans1.63% Short Ratio4.39 Perf Half Y-6.58%
Sales8.23B P/B1.52 EPS next Y7.10% ROA3.17% Short Interest9.79M Perf YTD9.82%
Book/sh64.95 P/C33.06 EPS next 5Y5.18% ROE5.60% 52W High114.44 -13.71% Perf Year-4.71%
Cash/sh2.99 P/FCF16.70 EPS past 3/5Y47.75% - ROIC3.56% 52W Low84.59 16.74% Perf 3Y-21.61%
Dividend Est.0.92 (0.94%) EV/EBITDA11.06 Sales past 3/5Y5.85% 3.22% Gross Margin60.94% Volatility2.02% 2.62% Perf 5Y-35.03%
Dividend TTM0.96 (0.97%) EV/Sales3.25 EPS Y/Y TTM-20.10% Oper. Margin16.07% ATR (14)2.50 Perf 10Y7.39%
Dividend Ex-DateDec 30, 2025 Quick Ratio1.10 Sales Y/Y TTM7.20% Profit Margin8.56% RSI (14)73.02 Recom2.62
Dividend Gr. 3/5Y0.00% 0.00% Current Ratio1.98 EPS Q/Q-41.28% SMA208.54% Beta0.58 Target Price102.00
Payout27.05% Debt/Eq0.61 Sales Q/Q10.90% SMA508.81% Rel Volume0.80 Prev Close99.25
Employees17000 LT Debt/Eq0.56 EarningsFeb 10 BMO SMA2003.76% Avg Volume2.23M Price98.75
IPOJul 25, 2001 Option/ShortYes / Yes EPS/Sales Surpr.0.92% 0.90% Trades Volume1,786,333 Change-0.50%
Date Action Analyst Rating Change Price Target Change
Feb-20-26Initiated William Blair Mkt Perform
Jan-09-26Downgrade Goldman Neutral → Sell $93
Jan-06-26Downgrade Raymond James Outperform → Mkt Perform
Jan-05-26Upgrade Evercore ISI In-line → Outperform $210
Dec-16-25Downgrade Robert W. Baird Outperform → Neutral $100
Nov-06-25Downgrade JP Morgan Overweight → Neutral $100
Sep-18-25Initiated Rothschild & Co Redburn Buy $130
Jul-15-25Upgrade Roth Capital Neutral → Buy $135
Dec-17-24Upgrade JP Morgan Neutral → Overweight $125 → $128
Sep-10-24Initiated Wolfe Research Peer Perform
Feb-20-26 09:39AM
Feb-19-26 11:04PM
Feb-18-26 11:01PM
Feb-17-26 12:33AM
Feb-12-26 01:26PM
08:04PM Loading…
Feb-11-26 08:04PM
07:55PM
06:41AM
03:57AM
02:07AM
12:31AM
Feb-10-26 12:55PM
12:44PM
11:11AM
09:30AM
08:19AM Loading…
08:19AM
07:40AM
06:45AM
06:36AM
06:30AM
Feb-09-26 02:08PM
Feb-08-26 10:07PM
Feb-05-26 10:42AM
09:15AM
Feb-04-26 10:00AM
Feb-03-26 11:38AM
10:00AM
Feb-02-26 11:03PM
Jan-27-26 08:00AM
Jan-21-26 07:11AM
10:35PM Loading…
Jan-20-26 10:35PM
08:12PM
Jan-15-26 09:40AM
07:30AM
07:10AM
Jan-14-26 01:12PM
01:12PM
07:20AM
Jan-13-26 07:49AM
Jan-09-26 04:38PM
Jan-06-26 08:05AM
Dec-26-25 07:17AM
Dec-23-25 09:40AM
Dec-22-25 07:30AM
Dec-18-25 08:00PM
11:30AM
08:28AM
Dec-17-25 07:58AM
07:00AM
Dec-16-25 09:33AM
09:09AM
07:30AM
Dec-11-25 11:23AM
Dec-10-25 04:55AM
Dec-05-25 11:30AM
Dec-04-25 09:50AM
Dec-02-25 09:40AM
Dec-01-25 05:00AM
Nov-26-25 07:32AM
Nov-21-25 06:51PM
Nov-18-25 05:17PM
Nov-14-25 09:40AM
07:30AM
Nov-11-25 06:55AM
Nov-07-25 07:30AM
Nov-06-25 12:11PM
06:56AM
Nov-05-25 04:01PM
02:38PM
12:50PM
12:17PM
12:08PM
12:00PM
09:30AM
07:45AM
06:43AM
06:42AM
06:40AM
06:30AM
Nov-03-25 10:11PM
Oct-28-25 07:30AM
Oct-27-25 09:40AM
09:20AM
Oct-23-25 12:10PM
Oct-21-25 02:05PM
08:58AM
08:56AM
07:30AM
Oct-20-25 06:31AM
Oct-14-25 06:18AM
Oct-13-25 09:49AM
Oct-10-25 08:35AM
07:04AM
Oct-08-25 07:30AM
Oct-07-25 09:00AM
Oct-03-25 09:40AM
07:30AM
12:01AM
Oct-02-25 10:13AM
09:40AM
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Yi SangGroup President, Asia PacificFeb 12 '26Sale96.491,00096,49017,670Feb 17 04:07 PM
Yi SangOfficerFeb 12 '26Proposed Sale96.491,00096,490Feb 12 12:05 PM
Winkler LoriSVP and CHRONov 28 '25Option Exercise0.0017906,956Dec 03 04:16 PM
Upadhyay SuketuExec VP, CFONov 10 '25Option Exercise0.0010,632059,485Nov 12 04:07 PM
Yi SangGroup President, Asia PacificSep 11 '25Sale103.581,200124,30218,584Sep 15 04:08 PM
Yi SangOfficerSep 11 '25Proposed Sale103.581,200124,302Sep 11 02:07 PM
Winkler LoriSVP and CHROSep 08 '25Sale104.151,500156,2256,833Sep 10 04:16 PM
Stellato Paul AVP, Controller, CAOSep 01 '25Option Exercise0.001,28104,112Sep 02 04:09 PM
Winkler LoriSVP and CHROAug 18 '25Sale102.491,500153,7358,333Aug 20 04:04 PM
Bezjak MarkOfficerAug 13 '25Proposed Sale102.237,500766,708Aug 13 11:36 AM
VAN ZUILEN WILFREDGroup Pres, EMEAJul 01 '25Option Exercise0.002,631022,165Jul 03 04:10 PM
Yi SangGroup President, Asia PacificJun 13 '25Sale92.5180074,01119,624Jun 17 04:06 PM
Yi SangGroup President, Asia PacificJun 11 '25Sale95.001,00095,00020,424Jun 13 04:39 PM
Yi SangOfficerJun 13 '25Proposed Sale92.5180074,011Jun 13 01:50 PM
Yi SangOfficerJun 11 '25Proposed Sale95.001,00095,000Jun 11 10:24 AM
Stellato Paul AVP, Controller & CAOJun 01 '25Option Exercise0.0062602,969Jun 03 04:38 PM
Phipps Chad FSr. VP/Gen Counsel/SecretaryMar 06 '25Option Exercise0.002,094060,862Mar 07 05:53 PM
Bezjak MarkPresident, AmericasMar 06 '25Option Exercise0.001,621013,772Mar 07 05:39 PM
Stellato Paul AVP, Controller & CAOMar 06 '25Option Exercise0.0060802,534Mar 07 05:38 PM
Winkler LoriSVP and CHROMar 06 '25Option Exercise0.001,757010,525Mar 07 05:37 PM
Winkler LoriSVP and CHROMar 05 '25Sale104.401,443150,6498,768Mar 07 05:37 PM
VAN ZUILEN WILFREDGroup Pres, EMEAMar 06 '25Option Exercise0.002,162020,103Mar 07 05:36 PM
Tornos IvanPresident & CEOMar 06 '25Option Exercise0.0010,268057,432Mar 07 05:35 PM
Upadhyay SuketuExec. VP, CFOMar 06 '25Option Exercise0.004,560050,882Mar 07 05:34 PM
Yi SangGroup President, Asia PacificMar 06 '25Option Exercise0.002,365021,424Mar 07 05:32 PM
Winkler LoriOfficerMar 05 '25Proposed Sale104.401,443150,653Mar 05 03:02 PM
Last Close
Feb 20  •  04:00PM ET
0.7319
Dollar change
-0.0277
Percentage change
-3.65
%
MYO Myomo Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.29 Insider Own7.40% Shs Outstand38.43M Perf Week-10.00%
Market Cap28.13M Forward P/E- EPS next Y-0.29 Insider Trans2.22% Shs Float35.59M Perf Month-24.84%
Enterprise Value27.88M PEG- EPS next Q-0.09 Inst Own42.13% Short Float13.26% Perf Quarter1.60%
Income-12.02M P/S0.68 EPS this Y-128.75% Inst Trans0.13% Short Ratio7.69 Perf Half Y-34.65%
Sales41.64M P/B1.92 EPS next Y20.77% ROA-47.71% Short Interest4.72M Perf YTD-19.57%
Book/sh0.38 P/C2.24 EPS next 5Y-4.96% ROE-100.51% 52W High6.30 -88.38% Perf Year-87.59%
Cash/sh0.33 P/FCF- EPS past 3/5Y55.74% 62.04% ROIC-48.32% 52W Low0.71 2.94% Perf 3Y7.65%
Dividend Est.- EV/EBITDA- Sales past 3/5Y32.93% 53.36% Gross Margin66.56% Volatility5.38% 7.77% Perf 5Y-95.26%
Dividend TTM- EV/Sales0.67 EPS Y/Y TTM-25.54% Oper. Margin-28.51% ATR (14)0.06 Perf 10Y-
Dividend Ex-Date- Quick Ratio2.10 Sales Y/Y TTM64.99% Profit Margin-28.86% RSI (14)31.65 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.49 EPS Q/Q-240.78% SMA20-11.82% Beta1.17 Target Price5.00
Payout- Debt/Eq0.84 Sales Q/Q9.59% SMA50-20.63% Rel Volume0.63 Prev Close0.76
Employees185 LT Debt/Eq0.70 EarningsNov 10 AMC SMA200-51.11% Avg Volume613.41K Price0.73
IPOJun 12, 2017 Option/ShortYes / Yes EPS/Sales Surpr.16.67% 6.92% Trades Volume384,698 Change-3.65%
Date Action Analyst Rating Change Price Target Change
Jul-31-24Initiated Craig Hallum Buy $7
May-20-24Initiated Lake Street Buy $7
Dec-15-23Initiated H.C. Wainwright Buy $6.50
Nov-11-20Upgrade ROTH Capital Neutral → Buy $5 → $7
May-27-20Initiated Dougherty & Company Buy $8.50
Oct-02-17Initiated H.C. Wainwright Buy $12
Nov-11-25 12:02AM
Nov-10-25 05:35PM
Nov-06-25 07:20AM
Aug-12-25 03:00PM
Aug-11-25 07:00PM
04:05PM Loading…
04:05PM
Aug-08-25 09:32AM
Aug-04-25 04:05PM
Jul-10-25 12:40AM
Jun-25-25 08:56AM
Jun-18-25 08:30AM
May-08-25 03:31AM
May-07-25 09:00PM
09:00PM
06:25PM
05:11PM Loading…
05:11PM
May-01-25 08:30AM
Apr-30-25 04:05PM
08:05AM
Apr-10-25 08:30AM
Apr-09-25 06:03AM
Mar-31-25 04:05PM
Mar-11-25 01:12PM
03:03AM
Mar-10-25 05:15PM
04:05PM
Mar-07-25 07:06AM
Mar-03-25 04:05PM
Dec-05-24 07:30AM
Dec-04-24 04:05PM
02:22AM Loading…
Nov-07-24 02:22AM
Nov-06-24 06:00PM
04:05PM
Nov-05-24 08:07AM
Oct-31-24 04:05PM
Oct-30-24 04:05PM
Oct-18-24 05:01PM
Oct-09-24 05:08PM
04:05PM
Sep-12-24 08:30AM
Sep-05-24 04:15PM
Aug-06-24 04:05PM
Jul-30-24 04:05PM
Jul-27-24 07:40AM
Jul-26-24 06:05PM
Jul-08-24 08:30AM
Jun-11-24 10:50AM
Jun-05-24 05:58PM
Jun-01-24 02:42AM
May-17-24 07:01PM
May-10-24 04:03PM
01:01PM
May-09-24 01:16PM
May-08-24 04:05PM
May-06-24 01:19PM
08:30AM
May-01-24 05:21PM
Mar-28-24 04:05PM
Mar-18-24 11:00AM
Mar-08-24 10:15AM
Mar-07-24 06:00PM
04:05PM
Mar-01-24 08:00AM
Feb-29-24 04:05PM
Jan-19-24 04:05PM
Jan-17-24 08:05AM
08:00AM
Dec-20-23 08:50AM
Dec-12-23 07:00AM
Dec-01-23 10:00AM
Nov-20-23 04:16PM
Nov-08-23 11:47AM
Nov-07-23 04:05PM
Nov-06-23 08:30AM
Nov-02-23 10:08AM
Oct-31-23 04:05PM
Aug-29-23 04:05PM
Aug-28-23 12:38PM
Aug-25-23 07:00AM
Aug-24-23 07:33PM
04:15PM
04:05PM
Aug-21-23 04:05PM
Aug-09-23 05:30PM
04:05PM
Aug-02-23 04:05PM
Jul-05-23 10:50AM
Jul-03-23 08:30AM
Jun-14-23 04:05PM
May-22-23 09:55AM
May-10-23 06:05PM
May-09-23 07:05PM
May-05-23 07:45AM
May-03-23 04:05PM
Apr-10-23 08:30AM
Mar-16-23 05:30AM
Mar-15-23 08:30AM
Mar-14-23 11:11AM
Mar-13-23 09:45AM
08:30AM
Myomo, Inc. is a wearable medical robotics company, which engages in the business of developing, designing, and producing myoelectric orthotics for people with neuromuscular disorders. The firm is also involved in selling products through various other sales channels including through orthotics and prosthetics providers, veterans' administration, and to distributors in certain accounts and geographic markets. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Burlington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIRK THOMAS FDirectorNov 20 '25Buy0.724,9023,529479,322Nov 24 04:04 PM
KIRK THOMAS FDirectorNov 21 '25Buy0.722,5351,825481,857Nov 24 04:04 PM
Crowley Thomas Aloysius Jr.DirectorNov 18 '25Buy0.734,0002,93875,748Nov 21 07:22 PM
Crowley Thomas Aloysius Jr.DirectorNov 19 '25Buy0.77385295479Nov 21 07:22 PM
KIRK THOMAS FDirectorAug 25 '25Buy1.1550,00057,500474,420Aug 26 08:10 AM
KIRK THOMAS FDirectorAug 18 '25Buy1.1050,00055,000424,420Aug 19 07:23 AM
GUDONIS PAUL RChief Executive OfficerAug 15 '25Buy0.9550,00047,2951,259,013Aug 18 07:51 AM
David HenryOfficerJun 30 '25Proposed Sale2.1923,58751,656Jun 30 08:12 PM
Harry KovelmanOfficerJun 28 '25Proposed Sale2.1913,05428,588Jun 30 08:04 PM
Harry KovelmanOfficerJun 06 '25Proposed Sale2.975,74317,057Jun 06 07:08 PM
David HenryOfficerJun 06 '25Proposed Sale2.978,37324,868Jun 06 06:50 PM
KIRK THOMAS FDirectorMay 15 '25Buy3.2536,824119,678344,700May 15 04:53 PM
KIRK THOMAS FDirectorMay 14 '25Buy3.251,9436,315307,876May 15 04:53 PM
GUDONIS PAUL RChief Executive OfficerMay 15 '25Buy3.2230,00096,6121,051,671May 15 04:36 PM
KIRK THOMAS FDirectorMay 12 '25Buy3.3550,000167,500305,933May 14 08:27 AM
KIRK THOMAS FDirectorMar 13 '25Buy5.007,40037,000255,933Mar 14 09:00 PM
Mitchell MicahChief Commercial OfficerMar 14 '25Sale5.1648,000247,565140,572Mar 14 05:36 PM
MICAH MITCHELLOfficerMar 14 '25Proposed Sale5.1648,000247,565Mar 14 05:24 PM
Kovelman HarryChief Medical OfficerMar 12 '25Sale5.5030,000165,01897,973Mar 13 04:41 PM
Micah MitchellOfficerMar 13 '25Proposed Sale5.221,2836,697Mar 13 04:31 PM
David HenryOfficerMar 13 '25Proposed Sale5.222,01910,539Mar 13 04:30 PM
Harry KovelmanOfficerMar 13 '25Proposed Sale5.221,4967,809Mar 13 04:28 PM
HARRY KOVELMANOfficerMar 12 '25Proposed Sale5.5030,000165,015Mar 12 04:59 PM
Last Close
Feb 20  •  04:00PM ET
5.79
Dollar change
-0.04
Percentage change
-0.69
%
INGN Inogen Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-1.00 Insider Own12.07% Shs Outstand27.15M Perf Week0.00%
Market Cap157.19M Forward P/E- EPS next Y-0.68 Insider Trans0.00% Shs Float23.87M Perf Month-8.96%
Enterprise Value50.91M PEG- EPS next Q-0.36 Inst Own74.81% Short Float3.43% Perf Quarter-15.47%
Income-25.38M P/S0.45 EPS this Y37.51% Inst Trans2.43% Short Ratio4.14 Perf Half Y-21.44%
Sales347.03M P/B0.80 EPS next Y28.04% ROA-8.28% Short Interest0.82M Perf YTD-13.84%
Book/sh7.26 P/C1.26 EPS next 5Y25.65% ROE-13.27% 52W High11.94 -51.51% Perf Year-43.68%
Cash/sh4.59 P/FCF- EPS past 3/5Y-75.31% - ROIC-11.95% 52W Low5.48 5.66% Perf 3Y-75.36%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-2.12% -1.49% Gross Margin49.79% Volatility3.20% 4.17% Perf 5Y-89.02%
Dividend TTM- EV/Sales0.15 EPS Y/Y TTM55.37% Oper. Margin-8.97% ATR (14)0.25 Perf 10Y-82.38%
Dividend Ex-Date- Quick Ratio2.75 Sales Y/Y TTM4.68% Profit Margin-7.31% RSI (14)43.03 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio3.14 EPS Q/Q22.14% SMA20-0.84% Beta1.78 Target Price13.00
Payout- Debt/Eq0.09 Sales Q/Q4.00% SMA50-8.85% Rel Volume0.89 Prev Close5.83
Employees766 LT Debt/Eq0.08 EarningsFeb 24 BMO SMA200-18.17% Avg Volume197.60K Price5.79
IPOFeb 14, 2014 Option/ShortYes / Yes EPS/Sales Surpr.3.75% 0.21% Trades Volume175,549 Change-0.69%
Date Action Analyst Rating Change Price Target Change
Jun-16-25Initiated B. Riley Securities Buy $14
May-22-25Upgrade Needham Hold → Buy $12
Feb-15-24Upgrade William Blair Mkt Perform → Outperform
Aug-08-23Downgrade JP Morgan Overweight → Neutral $15 → $8
Jul-14-23Downgrade Needham Buy → Hold
Jan-17-23Downgrade William Blair Outperform → Mkt Perform
Dec-09-21Upgrade Needham Hold → Buy $47
Nov-02-21Upgrade JP Morgan Underweight → Neutral $45
Aug-05-21Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Jun-04-21Upgrade William Blair Mkt Perform → Outperform
Feb-18-26 10:00AM
Feb-17-26 10:00AM
Feb-11-26 09:22PM
Feb-10-26 09:35AM
Feb-02-26 09:51AM
07:40AM Loading…
07:40AM
Jan-12-26 08:30AM
Jan-08-26 09:46AM
Jan-07-26 08:30AM
Jan-02-26 08:33AM
Dec-22-25 03:35PM
Dec-19-25 08:41AM
Dec-08-25 08:21AM
Dec-05-25 11:30AM
09:04AM
09:35AM Loading…
Nov-14-25 09:35AM
Nov-08-25 10:00AM
Nov-06-25 01:22PM
Nov-05-25 08:50AM
07:47AM
07:30AM
Nov-04-25 08:39AM
Oct-15-25 08:30AM
Sep-30-25 08:50AM
Sep-26-25 09:21AM
Sep-25-25 04:05PM
09:24AM
Sep-23-25 08:21AM
Sep-11-25 08:24AM
Sep-08-25 05:04PM
10:36AM Loading…
Sep-02-25 10:36AM
Aug-21-25 09:55AM
Aug-12-25 04:42AM
Aug-08-25 12:11PM
03:40AM
Aug-07-25 06:55PM
06:08PM
04:05PM
Aug-05-25 06:50PM
Jul-17-25 08:30AM
Jul-16-25 09:42AM
Jun-23-25 08:30AM
Jun-06-25 11:31AM
May-28-25 09:14AM
04:41AM
May-27-25 09:10AM
May-22-25 04:34PM
May-16-25 12:00PM
09:35AM
May-08-25 12:06PM
03:36AM
May-07-25 08:18PM
08:16PM
07:00PM
05:55PM
04:53PM
04:05PM
10:00AM
May-06-25 10:13AM
May-01-25 05:45PM
Apr-16-25 08:30AM
07:10AM
Mar-27-25 11:30AM
Mar-20-25 08:30AM
Mar-13-25 09:30AM
Feb-26-25 07:41AM
02:17AM
Feb-25-25 05:55PM
05:02PM
04:05PM
01:51AM
Feb-03-25 04:00PM
Jan-26-25 12:00PM
Jan-24-25 12:00PM
Jan-13-25 04:00PM
Dec-31-24 08:58AM
05:20AM
Dec-30-24 08:30AM
Nov-25-24 09:55AM
Nov-08-24 08:00PM
04:02AM
Nov-07-24 06:10PM
05:05PM
04:05PM
04:04PM
09:16AM
Nov-06-24 07:43AM
Nov-04-24 08:30AM
Oct-17-24 08:30AM
Oct-09-24 05:09PM
Oct-08-24 08:30AM
Sep-05-24 08:30AM
Aug-22-24 01:16PM
Aug-08-24 12:00PM
Aug-07-24 11:34AM
Aug-06-24 06:05PM
05:06PM
04:05PM
Jul-22-24 06:24AM
Jul-16-24 08:30AM
Inogen, Inc. is a global medical technology company offering innovative respiratory products for use in the homecare setting. It supports patient respiratory care by developing, manufacturing, and marketing innovative best-in-class respiratory therapy devices used to deliver care to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Beverly, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ramade GregoireChief Commercial OfficerDec 01 '25Option Exercise0.0031,566050,189Dec 02 04:08 PM
Smith Kevin Raymond MerrillCEO and PresidentDec 01 '25Option Exercise0.0028,3340100,108Dec 02 04:06 PM
Smith Kevin P.EVP, Bus Dev, GC & SecSep 01 '25Option Exercise0.0018,135020,821Sep 03 05:02 PM
Bourque Michael J.EVP, CFO & TreasurerMar 01 '25Option Exercise0.0025,000025,600Mar 04 06:42 PM
Bourque Michael J.EVP, CFO & TreasurerMar 03 '25Buy8.323,00024,96047,646Mar 04 06:42 PM
Smith Kevin Raymond MerrillCEO and PresidentMar 01 '25Option Exercise0.0028,333044,387Mar 04 06:41 PM
Smith Kevin Raymond MerrillCEO and PresidentMar 03 '25Buy8.5611,709100,24570,274Mar 04 06:41 PM
Last Close
Feb 20  •  04:00PM ET
197.06
Dollar change
-0.94
Percentage change
-0.47
%
MSA MSA Safety Inc daily Stock Chart
Index- P/E27.80 EPS (ttm)7.09 Insider Own6.16% Shs Outstand38.91M Perf Week-2.96%
Market Cap7.64B Forward P/E20.72 EPS next Y9.51 Insider Trans-0.16% Shs Float36.39M Perf Month7.00%
Enterprise Value8.12B PEG2.14 EPS next Q1.86 Inst Own89.52% Short Float3.43% Perf Quarter25.58%
Income278.86M P/S4.08 EPS this Y10.56% Inst Trans-4.43% Short Ratio5.15 Perf Half Y15.62%
Sales1.87B P/B5.62 EPS next Y8.49% ROA11.72% Short Interest1.25M Perf YTD23.05%
Book/sh35.04 P/C46.03 EPS next 5Y9.70% ROE22.22% 52W High208.92 -5.68% Perf Year23.93%
Cash/sh4.28 P/FCF25.86 EPS past 3/5Y15.86% 17.57% ROIC14.04% 52W Low127.86 54.12% Perf 3Y40.56%
Dividend Est.2.14 (1.09%) EV/EBITDA17.14 Sales past 3/5Y7.06% 6.82% Gross Margin47.16% Volatility2.31% 2.29% Perf 5Y15.94%
Dividend TTM2.12 (1.08%) EV/Sales4.33 EPS Y/Y TTM-1.70% Oper. Margin21.44% ATR (14)4.67 Perf 10Y359.56%
Dividend Ex-DateFeb 13, 2026 Quick Ratio1.82 Sales Y/Y TTM3.69% Profit Margin14.87% RSI (14)66.14 Recom2.14
Dividend Gr. 3/5Y4.89% 4.19% Current Ratio3.01 EPS Q/Q-0.40% SMA203.88% Beta0.95 Target Price210.33
Payout29.63% Debt/Eq0.47 Sales Q/Q2.24% SMA5011.55% Rel Volume1.45 Prev Close198.00
Employees5300 LT Debt/Eq0.45 EarningsFeb 11 AMC SMA20016.18% Avg Volume242.15K Price197.06
IPOMar 17, 1980 Option/ShortYes / Yes EPS/Sales Surpr.5.35% 0.57% Trades Volume351,643 Change-0.47%
Date Action Analyst Rating Change Price Target Change
Feb-03-26Initiated JP Morgan Neutral $200
Jul-16-25Resumed Stifel Hold $182
Dec-19-24Initiated DA Davidson Buy $195
Dec-12-24Initiated Jefferies Hold $200
Nov-05-24Initiated B. Riley Securities Buy $200
Jun-12-23Upgrade William Blair Mkt Perform → Outperform
Dec-07-21Upgrade Sidoti Neutral → Buy $183
Mar-24-20Upgrade Sidoti Neutral → Buy $113
Jan-10-19Initiated William Blair Mkt Perform
Dec-21-18Downgrade Robert W. Baird Outperform → Neutral
Feb-18-26 12:38AM
Feb-17-26 11:34PM
11:02PM
Feb-13-26 01:09AM
Feb-12-26 04:09PM
02:50PM Loading…
02:50PM
08:30AM
Feb-11-26 06:30PM
05:55PM
05:02PM
04:56PM
04:45PM
Feb-09-26 10:02PM
10:56AM
Feb-04-26 05:02PM
04:30PM Loading…
Jan-29-26 04:30PM
08:35AM
Jan-15-26 08:30AM
Jan-06-26 03:19PM
Jan-05-26 10:32PM
Dec-09-25 09:19AM
Nov-17-25 11:00PM
Nov-05-25 04:30PM
Nov-04-25 08:15AM
07:35AM
12:32AM
Oct-31-25 06:00PM
08:30AM
Oct-30-25 03:55PM
03:36PM
02:40PM Loading…
Oct-29-25 02:40PM
Oct-28-25 05:45PM
04:46PM
04:41PM
04:30PM
09:29AM
Oct-27-25 09:23AM
Oct-26-25 11:03PM
Oct-21-25 11:31PM
Oct-17-25 11:31PM
Oct-15-25 08:34AM
Oct-14-25 04:30PM
Oct-01-25 12:40AM
Sep-18-25 12:04AM
Sep-15-25 08:35AM
Sep-12-25 12:36AM
Sep-08-25 09:06AM
Aug-19-25 08:16AM
Aug-14-25 09:47AM
Aug-13-25 04:30PM
Aug-12-25 11:26PM
03:26AM
Aug-11-25 11:20AM
Aug-05-25 12:42PM
Aug-04-25 07:00PM
05:50PM
05:39PM
04:52PM
04:30PM
09:24AM
08:30AM
Aug-02-25 11:00PM
Aug-01-25 11:52PM
11:30AM
Jul-31-25 10:00AM
Jul-28-25 10:00AM
Jul-21-25 04:30PM
Jun-25-25 02:17AM
Jun-11-25 11:37PM
Jun-09-25 02:25PM
May-20-25 08:46AM
May-19-25 08:59AM
May-15-25 04:30PM
May-08-25 07:35AM
12:37AM
May-07-25 04:53PM
04:30PM
May-04-25 08:30PM
May-03-25 01:26AM
May-02-25 08:30AM
May-01-25 03:13AM
01:41AM
Apr-30-25 10:47PM
Apr-29-25 05:55PM
04:49PM
04:48PM
04:30PM
Apr-28-25 07:24PM
04:30PM
03:00AM
Apr-22-25 09:02AM
Apr-21-25 07:40AM
Apr-16-25 12:00PM
Apr-15-25 04:30PM
Apr-10-25 09:52AM
07:45AM
Apr-09-25 05:15PM
08:15AM
Mar-28-25 05:01AM
Mar-27-25 05:16AM
MSA Safety, Inc. engages in the development, manufacture, and sale of safety products, technology, and solutions. It operates through the following geographical segments: Americas, International, and Corporate. The Americas segment includes manufacturing, research, and development facilities in the U.S., Mexico, and Brazil. The International segment consists of companies in Europe, the Middle East, Africa, and the Asia Pacific region. The Corporate segment focuses on the general and administrative expenses incurred in its corporate headquarters. The company was founded by John Ryan and George Deike on June 14,1914 and is headquartered in Butler, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Buck Jonathan D.Chief Accounting OfficerFeb 17 '26Sale203.481,100223,8283,234Feb 18 09:12 AM
Buck Jonathan D.Chief Accounting OfficerNov 25 '25Sale161.0033353,6134,434Nov 26 08:44 AM
Sciullo Stephanie LPresidentSep 12 '25Sale169.512,361400,2139,083Sep 15 10:04 AM
Sciullo Stephanie LOfficerSep 12 '25Proposed Sale172.292,361406,777Sep 12 09:29 AM
Brody Elyse LOfficerSep 11 '25Proposed Sale172.301,034178,154Sep 11 03:57 PM
Sciullo Stephanie LOfficerSep 11 '25Proposed Sale172.385,000861,880Sep 11 02:40 PM
Roberts Rebecca BFormer DirectorAug 22 '25Proposed Sale175.1025043,774Aug 22 01:02 PM
Roberts Rebecca BFormer DirectorJul 16 '25Proposed Sale171.0043975,069Jul 16 04:41 PM
Roberts Rebecca BFormer DirectorJun 10 '25Proposed Sale166.7150083,355Jun 10 11:34 AM
Vartanian Nishan J.ChairmanMay 13 '25Sale161.3230,0004,839,60035,401May 14 09:50 AM
NISHAN J VARTANIANDirectorMay 13 '25Proposed Sale161.3230,0004,839,501May 13 04:34 PM
Buck Jonathan D.Chief Accounting OfficerFeb 24 '25Sale159.00717114,0033,673Feb 24 01:39 PM
Last Close
Feb 20  •  04:00PM ET
5.15
Dollar change
-0.05
Percentage change
-0.96
%
APT Alpha Pro Tech Ltd daily Stock Chart
Index- P/E14.99 EPS (ttm)0.34 Insider Own16.48% Shs Outstand10.28M Perf Week1.18%
Market Cap53.35M Forward P/E- EPS next Y- Insider Trans-0.82% Shs Float8.65M Perf Month12.45%
Enterprise Value43.80M PEG- EPS next Q- Inst Own28.07% Short Float0.49% Perf Quarter15.21%
Income3.68M P/S0.90 EPS this Y- Inst Trans-0.59% Short Ratio1.30 Perf Half Y11.47%
Sales59.10M P/B0.85 EPS next Y- ROA5.00% Short Interest0.04M Perf YTD15.99%
Book/sh6.08 P/C3.02 EPS next 5Y- ROE5.91% 52W High6.20 -16.94% Perf Year-5.85%
Cash/sh1.70 P/FCF20.21 EPS past 3/5Y-11.87% 8.90% ROIC5.28% 52W Low4.06 26.85% Perf 3Y18.66%
Dividend Est.- EV/EBITDA9.98 Sales past 3/5Y-5.55% 4.39% Gross Margin36.81% Volatility4.18% 5.14% Perf 5Y-66.77%
Dividend TTM- EV/Sales0.74 EPS Y/Y TTM-5.75% Oper. Margin6.03% ATR (14)0.24 Perf 10Y217.90%
Dividend Ex-Date- Quick Ratio7.70 Sales Y/Y TTM-0.32% Profit Margin6.23% RSI (14)55.27 Recom-
Dividend Gr. 3/5Y- - Current Ratio14.10 EPS Q/Q20.75% SMA201.40% Beta0.64 Target Price-
Payout0.00% Debt/Eq0.13 Sales Q/Q3.75% SMA507.78% Rel Volume1.31 Prev Close5.20
Employees130 LT Debt/Eq0.11 Earnings- SMA2009.18% Avg Volume32.61K Price5.15
IPOApr 04, 1994 Option/ShortYes / Yes EPS/Sales Surpr.- - Trades Volume42,762 Change-0.96%
Date Action Analyst Rating Change Price Target Change
Mar-30-10Downgrade Dougherty & Company Buy → Neutral $5 → $2.50
Oct-16-09Initiated Dougherty & Company Buy $10
Jan-21-26 07:20AM
Nov-18-25 04:30PM
Nov-10-25 08:18AM
Nov-05-25 09:00AM
Aug-07-25 09:00AM
04:29AM Loading…
Aug-04-25 04:29AM
Jun-28-25 09:10AM
Jun-27-25 09:00AM
May-23-25 06:32PM
May-08-25 09:00AM
Mar-12-25 09:00AM
Dec-23-24 04:00PM
Nov-06-24 09:00AM
Oct-02-24 03:30PM
Aug-07-24 09:00AM
09:00AM Loading…
May-08-24 09:00AM
Apr-03-24 11:30AM
Mar-25-24 07:00PM
Mar-13-24 09:00AM
Nov-27-23 09:00AM
Nov-07-23 03:21PM
09:00AM
Aug-08-23 09:00AM
Jun-22-23 03:30PM
May-09-23 09:00AM
Apr-21-23 02:37PM
Mar-16-23 09:00AM
Dec-28-22 02:33PM
Dec-15-22 09:00AM
Nov-12-22 11:37AM
09:00AM Loading…
Nov-07-22 09:00AM
Aug-04-22 09:00AM
Jun-23-22 09:00AM
May-10-22 09:00AM
May-06-22 06:40AM
Mar-09-22 09:00AM
Jan-20-22 09:38AM
Dec-24-21 01:38AM
Dec-17-21 11:38PM
12:38PM
Dec-15-21 09:00AM
Dec-11-21 05:38AM
Nov-04-21 09:00AM
Aug-04-21 09:00AM
Jun-30-21 10:26AM
May-24-21 09:00AM
May-06-21 10:20AM
09:00AM
Apr-28-21 12:34PM
Mar-19-21 08:32AM
Mar-17-21 11:47AM
Mar-16-21 12:36PM
Mar-09-21 10:15AM
09:00AM
Feb-27-21 02:50AM
Feb-04-21 02:04PM
Jan-19-21 11:19PM
Dec-16-20 11:17AM
Dec-14-20 11:23PM
Dec-02-20 09:47PM
Nov-15-20 07:16AM
Nov-13-20 09:23AM
08:41AM
Nov-05-20 09:00AM
Nov-02-20 02:15PM
Oct-23-20 09:00AM
Oct-19-20 05:03PM
04:15PM
Oct-16-20 06:38AM
Oct-15-20 09:15AM
Oct-08-20 09:15AM
Oct-07-20 09:15AM
Oct-01-20 09:15AM
Sep-28-20 09:15AM
Sep-25-20 09:15AM
Sep-24-20 09:15AM
Sep-22-20 09:15AM
09:00AM
Sep-20-20 08:39AM
Aug-25-20 06:01AM
Aug-04-20 03:00PM
12:26PM
09:00AM
06:02AM
Jul-31-20 02:14PM
Jul-20-20 04:03PM
Jul-17-20 06:27AM
Jul-13-20 02:05PM
Jun-26-20 03:00PM
Jun-25-20 09:00AM
Jun-19-20 03:16PM
Jun-10-20 04:07PM
03:29PM
May-22-20 06:46AM
May-15-20 07:54AM
May-06-20 09:00AM
Apr-22-20 06:21AM
Apr-09-20 03:30PM
10:49AM
Apr-08-20 04:06PM
Alpha Pro Tech Ltd. engages in the business of protecting people, products and environment. It develops, manufactures and markets disposable and limited use protective apparel products for the industries, clean room, medical and dental markets. The company operates through the Disposable Protective Apparel and Building Supply segments. The Disposable Protective Apparel segment includes many different styles of disposable products, such as shoe covers, bouffant caps, gowns, coveralls, lab coats, frocks and other miscellaneous products. The Building Supply segment consists of a line of construction supply weatherization products, namely house wrap and synthetic roof underlayment. The company was founded in 1983 and is headquartered in Markham, Canada.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Buchan JamesDirectorDec 05 '25Sale4.614,74021,8515,615Dec 08 11:03 AM
James W BuchanDirectorDec 12 '25Proposed Sale4.614,74021,850Dec 08 10:58 AM
James W BuchanDirectorDec 12 '25Proposed Sale4.614,74021,850Dec 08 10:47 AM
Buchan JamesDirectorSep 09 '25Sale4.869,41345,7254,740Sep 11 04:19 PM
James W BuchanDirectorSep 09 '25Proposed Sale8.509,41380,000Sep 11 04:18 PM
RITOTA JOHNDirectorMar 18 '25Sale5.159,41348,45649,790Mar 20 11:28 AM
JOHN P. RITOTADirectorMar 18 '25Proposed Sale5.159,41348,456Mar 18 04:25 PM
Last Close
Feb 20  •  04:00PM ET
15.46
Dollar change
+0.25
Percentage change
1.64
%
AVNS Avanos Medical Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-10.18 Insider Own3.80% Shs Outstand46.42M Perf Week4.74%
Market Cap717.64M Forward P/E15.46 EPS next Y1.00 Insider Trans-0.84% Shs Float44.65M Perf Month20.22%
Enterprise Value780.84M PEG- EPS next Q0.25 Inst Own98.69% Short Float7.64% Perf Quarter37.54%
Income-468.90M P/S1.03 EPS this Y-33.33% Inst Trans-10.76% Short Ratio6.16 Perf Half Y36.09%
Sales699.90M P/B0.92 EPS next Y11.11% ROA-34.41% Short Interest3.41M Perf YTD37.67%
Book/sh16.76 P/C10.18 EPS next 5Y-2.53% ROE-46.68% 52W High16.63 -7.04% Perf Year-0.13%
Cash/sh1.52 P/FCF9.58 EPS past 3/5Y- -54.63% ROIC-52.52% 52W Low9.30 66.18% Perf 3Y-48.38%
Dividend Est.- EV/EBITDA9.72 Sales past 3/5Y-2.61% -0.28% Gross Margin51.76% Volatility2.88% 3.40% Perf 5Y-66.07%
Dividend TTM- EV/Sales1.12 EPS Y/Y TTM-3090.51% Oper. Margin5.74% ATR (14)0.48 Perf 10Y-39.04%
Dividend Ex-Date- Quick Ratio1.36 Sales Y/Y TTM2.70% Profit Margin-67.00% RSI (14)75.66 Recom3.00
Dividend Gr. 3/5Y- - Current Ratio2.38 EPS Q/Q-132.72% SMA209.56% Beta1.05 Target Price14.00
Payout- Debt/Eq0.17 Sales Q/Q4.34% SMA5021.57% Rel Volume0.85 Prev Close15.21
Employees2227 LT Debt/Eq0.15 EarningsFeb 24 BMO SMA20028.44% Avg Volume553.94K Price15.46
IPOOct 21, 2014 Option/ShortYes / Yes EPS/Sales Surpr.83.33% 8.09% Trades Volume470,080 Change1.64%
Date Action Analyst Rating Change Price Target Change
Jul-25-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
May-22-23Initiated CL King Buy $31
Aug-04-21Downgrade Stephens Overweight → Equal-Weight $60 → $45
Apr-13-20Upgrade Barclays Underweight → Equal Weight $30
Nov-07-19Downgrade Stifel Buy → Hold $45 → $35
Nov-06-19Downgrade Raymond James Outperform → Mkt Perform
Oct-16-18Initiated Barclays Equal Weight $69
Aug-21-18Upgrade Raymond James Mkt Perform → Outperform
Feb-19-26 09:15AM
Feb-17-26 05:25PM
Feb-16-26 04:30PM
Feb-09-26 07:45AM
Feb-04-26 06:55PM
08:00AM Loading…
Feb-03-26 08:00AM
Jan-29-26 01:32PM
07:10AM
Jan-26-26 10:20AM
Jan-20-26 08:00AM
Jan-15-26 01:01PM
Jan-09-26 07:00AM
Jan-07-26 08:25PM
Jan-06-26 05:14AM
Dec-17-25 06:08AM
11:30AM Loading…
Dec-05-25 11:30AM
Nov-06-25 08:35AM
Nov-05-25 04:03PM
08:15AM
07:26AM
07:00AM
Nov-04-25 06:25PM
Oct-27-25 10:31AM
Oct-23-25 08:00AM
Sep-18-25 08:42AM
Sep-15-25 07:00AM
Sep-10-25 12:35PM
Aug-06-25 01:08PM
Aug-05-25 07:45AM
06:45AM
06:41AM Loading…
06:41AM
06:30AM
Jul-31-25 04:15PM
Jul-24-25 10:20AM
Jul-16-25 09:39AM
Jul-15-25 05:25AM
Jun-09-25 07:15AM
May-13-25 09:16AM
May-09-25 06:51AM
May-07-25 12:50PM
03:12AM
12:33AM
May-06-25 09:47AM
08:25AM
07:25AM
07:00AM
Apr-28-25 07:47AM
Apr-25-25 04:49AM
Apr-17-25 12:24PM
Apr-03-25 07:54AM
Apr-02-25 07:00AM
Mar-28-25 11:30AM
Mar-24-25 05:29AM
Mar-17-25 07:30AM
Mar-11-25 10:26AM
Feb-27-25 03:02AM
02:13AM
Feb-26-25 08:25AM
07:33AM
07:00AM
Feb-19-25 08:54AM
Jan-28-25 09:12AM
Jan-27-25 10:07AM
Jan-06-25 08:54AM
Nov-12-24 12:07PM
Nov-11-24 09:38AM
Nov-08-24 04:16PM
Nov-05-24 07:00AM
Oct-31-24 09:40AM
03:11AM
03:10AM
Oct-30-24 08:00AM
07:00AM
06:45AM
Oct-23-24 06:19AM
Oct-17-24 12:00PM
Oct-09-24 03:32PM
09:40AM
Oct-02-24 08:36AM
Sep-19-24 09:40AM
Sep-13-24 09:50AM
Sep-09-24 10:54AM
10:29AM
Aug-22-24 09:40AM
Aug-12-24 10:36AM
Aug-05-24 09:40AM
Aug-01-24 12:55PM
Jul-31-24 08:20AM
07:16AM
07:00AM
Jul-26-24 12:43PM
Jul-24-24 06:14PM
Jul-01-24 07:00AM
May-13-24 07:15AM
May-06-24 10:54AM
May-03-24 01:14PM
04:21AM
03:31AM
May-02-24 11:56AM
08:47AM
Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Holbrook KerrSVP, Chief Commercial OfficerNov 18 '25Sale11.0015,000165,01483,860Nov 19 01:45 PM
Holbrook KerrFormer OfficerNov 18 '25Proposed Sale11.0015,000165,014Nov 18 11:45 AM
BLACKFORD GARYDirectorAug 13 '25Buy10.9940,000439,80040,000Aug 15 12:02 PM
BLACKFORD GARYDirectorAug 13 '25Buy10.9720,000219,50091,593Aug 15 12:02 PM
Holbrook KerrSVP, Chief Commercial OfficerMar 06 '25Sale15.257,000106,77882,047Mar 10 11:50 AM
Holbrook KerrOfficerMar 06 '25Proposed Sale15.257,000106,780Mar 06 05:05 PM
James MojiradeSVP, General CounselMar 04 '25Option Exercise0.008,039078,352Mar 06 02:25 PM
Woody Joseph FralinFormer Chief Executive OfficerMar 04 '25Option Exercise0.0032,1580453,203Mar 06 02:25 PM
Holbrook KerrSVP, Chief Commercial OfficerMar 04 '25Option Exercise0.005,145092,393Mar 06 02:24 PM
Hurley John JosephPrincipal Accounting OfficerMar 04 '25Option Exercise0.00107010,172Mar 06 02:23 PM
Greiner MichaelInterim CEOMar 04 '25Option Exercise0.0012,1490214,235Mar 06 02:22 PM
Last Close
Feb 20  •  04:00PM ET
190.02
Dollar change
+0.62
Percentage change
0.33
%
ALGN Align Technology, Inc daily Stock Chart
IndexS&P 500 P/E33.58 EPS (ttm)5.66 Insider Own6.66% Shs Outstand71.75M Perf Week3.35%
Market Cap13.63B Forward P/E15.55 EPS next Y12.22 Insider Trans-0.17% Shs Float66.97M Perf Month11.81%
Enterprise Value12.62B PEG1.82 EPS next Q2.31 Inst Own95.19% Short Float2.88% Perf Quarter43.65%
Income410.35M P/S3.38 EPS this Y7.28% Inst Trans-6.68% Short Ratio1.47 Perf Half Y32.34%
Sales4.03B P/B3.46 EPS next Y8.37% ROA6.59% Short Interest1.93M Perf YTD21.69%
Book/sh54.93 P/C12.45 EPS next 5Y8.55% ROE10.39% 52W High208.30 -8.78% Perf Year-4.06%
Cash/sh15.26 P/FCF24.06 EPS past 3/5Y7.01% -24.09% ROIC9.93% 52W Low122.00 55.75% Perf 3Y-40.00%
Dividend Est.- EV/EBITDA15.68 Sales past 3/5Y2.61% 10.30% Gross Margin71.66% Volatility3.02% 3.75% Perf 5Y-68.29%
Dividend TTM- EV/Sales3.13 EPS Y/Y TTM0.61% Oper. Margin15.22% ATR (14)6.72 Perf 10Y200.24%
Dividend Ex-Date- Quick Ratio1.24 Sales Y/Y TTM0.90% Profit Margin10.17% RSI (14)63.24 Recom2.17
Dividend Gr. 3/5Y- - Current Ratio1.36 EPS Q/Q35.72% SMA206.90% Beta1.79 Target Price197.85
Payout0.00% Debt/Eq0.02 Sales Q/Q5.26% SMA5012.17% Rel Volume0.79 Prev Close189.40
Employees20945 LT Debt/Eq0.02 EarningsFeb 04 AMC SMA20018.71% Avg Volume1.31M Price190.02
IPOJan 26, 2001 Option/ShortYes / Yes EPS/Sales Surpr.10.63% 1.41% Trades Volume1,036,972 Change0.33%
Date Action Analyst Rating Change Price Target Change
Feb-09-26Upgrade HSBC Securities Hold → Buy $200
Dec-09-25Initiated Barclays Equal Weight $170
Oct-10-25Downgrade Jefferies Buy → Hold $140
Jul-31-25Downgrade Morgan Stanley Overweight → Equal-Weight $154
Apr-25-25Downgrade HSBC Securities Buy → Hold $170
Feb-14-25Initiated Wells Fargo Overweight $255
Jan-06-25Upgrade Leerink Partners Market Perform → Outperform $235 → $280
Dec-04-24Initiated Mizuho Outperform $295
Oct-10-24Initiated Needham Hold
Feb-26-24Initiated Leerink Partners Market Perform $310
Feb-20-26 09:11AM
Feb-19-26 08:33AM
08:16AM
08:09AM
Feb-18-26 08:55AM
10:07AM Loading…
Feb-17-26 10:07AM
09:42AM
Feb-16-26 10:05AM
Feb-12-26 09:23AM
09:18AM
08:24AM
Feb-11-26 08:17AM
12:34AM
Feb-10-26 07:25PM
01:00PM
10:43AM Loading…
10:43AM
Feb-09-26 10:48AM
Feb-06-26 10:48AM
09:40AM
09:40AM
08:07AM
08:03AM
Feb-05-26 10:25AM
10:02AM
08:09AM
07:35AM
06:58AM
12:37AM
Feb-04-26 06:52PM
06:14PM
06:00PM Loading…
06:00PM
05:20PM
05:19PM
04:23PM
04:06PM
Feb-03-26 09:15AM
09:15AM
08:29AM
Feb-02-26 10:16PM
05:00PM
Jan-30-26 09:20AM
Jan-29-26 10:00AM
09:55AM
08:02AM
Jan-28-26 10:00AM
Jan-23-26 03:58AM
Jan-22-26 09:09AM
Jan-21-26 07:09AM
Jan-13-26 11:01PM
05:00PM
Jan-07-26 11:32PM
09:31AM
Jan-05-26 07:17AM
Jan-02-26 08:30AM
Dec-31-25 05:47AM
Dec-30-25 08:00AM
Dec-23-25 12:06PM
12:16AM
Dec-16-25 09:50AM
Dec-12-25 04:04AM
Dec-11-25 06:39AM
Dec-10-25 09:40AM
Dec-09-25 09:15AM
07:28AM
Dec-08-25 09:00PM
Dec-03-25 03:55PM
Dec-01-25 07:54AM
Nov-28-25 11:30AM
Nov-25-25 07:02PM
01:01PM
09:50AM
Nov-24-25 08:00PM
07:33AM
Nov-23-25 10:34PM
Nov-21-25 06:35PM
Nov-19-25 09:41AM
Nov-17-25 12:16PM
Nov-11-25 07:38PM
Nov-10-25 07:50AM
Nov-05-25 12:36AM
Nov-04-25 04:01PM
Nov-03-25 04:02PM
Oct-30-25 01:16PM
12:26PM
12:24PM
10:09AM
09:33AM
01:34AM
Oct-29-25 05:49PM
05:30PM
05:20PM
04:18PM
04:03PM
04:00PM
04:00PM
12:58PM
Oct-27-25 11:17PM
Oct-23-25 10:00AM
Oct-22-25 10:00AM
Oct-20-25 08:57AM
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad's CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Morici JohnEVP, CHIEF FINANCIAL OFFICERFeb 18 '26Sale189.317,9691,508,6468,237Feb 20 07:59 PM
John MoriciOfficerFeb 12 '26Proposed Sale185.957,9691,481,836Feb 12 04:43 PM
HOGAN JOSEPH MPRESIDENT AND CEOAug 01 '25Buy131.497,576996,131184,945Aug 01 04:05 PM
Conroy Kevin TDirectorMay 21 '25Option Exercise0.001,14801,808May 22 05:49 PM
SIEGEL SUSAN EDirectorMay 21 '25Option Exercise0.001,14808,978May 22 05:14 PM
Saia Andrea LynnDirectorMay 21 '25Option Exercise0.001,148015,573May 22 05:13 PM
Poul MojdehDirectorMay 21 '25Option Exercise0.001,14801,808May 22 05:12 PM
Myong AnneDirectorMay 21 '25Option Exercise0.001,14808,085May 22 05:12 PM
MORROW GEORGE JDirectorMay 21 '25Option Exercise0.001,14803,291May 22 05:11 PM
LARKIN C RAYMOND JRDirectorMay 21 '25Option Exercise0.001,531025,128May 22 05:10 PM
LACOB JOSEPHDirectorMay 21 '25Option Exercise0.001,1480134,171May 22 05:09 PM
Dallas Kevin JDirectorMay 21 '25Option Exercise0.001,148014,423May 22 05:08 PM